Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Mar 26;15(3):e0229463. doi: 10.1371/journal.pone.0229463

Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats

Shivasharanappa Nayakwadi 1,2,*, Ramith Ramu 3, Anil Kumar Sharma 1,4, Vivek Kumar Gupta 5, K Rajukumar 6, Vijay Kumar 1, Prithvi S Shirahatti 7, Rashmi L 8, Kanthesh M Basalingappa 9
Editor: Natarajan Aravindan10
PMCID: PMC7098593  PMID: 32214355

Abstract

Food and feeds contaminated with mycotoxins have been a threat to the rearing industry by causing some of the most fatal toxic reactions not only in the farm animals but also in humans who consume them. Toxicity to juvenile goats was induced by feed contamination with T-2 toxin (at 10 and 20 ppm dosage; group I and II, respectively). The toxicity impact was assessed on days 15 and 30 post treatment with respect to growth performance, oxidative stress, apoptotic studies and detailed pathomorphology. The study revealed that apart from the obvious clinical toxicosis (weakness, lethargy, and retardation in growth), the toxin fed groups also exhibited significant haematological (reduced hemoglobin, total leukocyte and thrombocyte counts) and biochemical changes (increased levels of oxidative stress markers with concomitant decrease in levels of serum and tissue catalase and superoxide dismutase). The pathomorphological and histological alterations suggested that the liver and intestine were the most affected organs. Ultra-structurally, varying degrees of degeneration, cytoplasmic vacuolations and pleomorphic mitochondria were observed in the hepatocytes and the enterocytes of the intestine. Kidney also revealed extensive degeneration of the cytoplasmic organelles with similar condensation of the heterochromatin whereas the neuronal degeneration was characterized by circular, whirling structures. In addition, the central vein and portal triad of the hepatocytes, cryptic epithelial cells of the intestine, MLNs in the lymphoid follicles, PCT and DCT of the nephronal tissues and the white pulp of the spleen exhibited extensive apoptosis. In this study, it was also observed that the expression of HSPs, pro-apoptotic proteins and pro-inflammatory cytokines were significantly upregulated in response to the toxin treatment. These results suggest that the pathogenesis of T-2 toxicosis in goats employs oxidative, apoptotic and inflammatory mechanisms.

Introduction

Mycotoxins viz.,aflatoxins, zearelenone, ochratoxins, fumonisins, citrinins and trichothecenes are the secondary metabolites produced by fungi responsible for mycotoxicosis in animals. Recent studies have reported the consequences of food contamination with mycotoxins, which are known to pose a major problem not only in animals but also to humans, causing significant economic and international trade implications [1]. As a result of the mycotoxin contamination in animal feed, there is reduced feed intake and at times feed refusal, reduced body weight due to inefficient of feed conversions, immune- suppression leading to frequent diseases, reduced reproductive ability [25]. Trichothecenes are a class of mycotoxins that are identified as a major threat to animals and healthcare. Most toxic trichothecenes are deoxynivalenol (DON), nivalenol (NIV), HT-2, diacetoxyscirpenol (DAS) and T-2 toxin[6]. Of these, T-2 toxin, mainly produced by Fusarium species, is the most deadly toxin with cytotoxic potential. This toxin has been considered to elicit fatal reactions among the animals and humans upon consumption [7]. The production of toxins by the fungi occur at ambient temperature of 0–32°C and moisture content [8,9]. Frequently contaminated grains are corn, wheat, rye, oats and barley. Studies have shown that T-2 toxicity leads to reduced feed consumption and milk production, absence of estrus cycle, gastroenteritis, intestinal hemorrhages and necrosis in cattle [1017],. The T-2 toxicity has also been well studied in laboratory animals such as sheep[18,19], pigs[20] and poultry[21]. However, toxicity in goat husbandry is not much explored.

It is observed that the presence of antioxidant scavengers increase the toxicity of the mycotoxins, suggesting that the toxicity is probably augmented by the presence of oxidative stress. Heat shock proteins (HSPs) play a pivotal role in rendering a protective shield towards oxidative damage induced by the mycotoxins. Studies have confirmed the induction of high ROS generation by T-2 toxin, which in turn increases the levels of Hsp70. Therefore, the existence of an intricate relationship between oxidative stress and HSPs can be used as a potent biomarker for assessing oxidative stress [2224]. Oxidative stress decides the apoptotic fate of the cell by eliciting a cascade of pro-apoptotic pathways. In addition, T-2 toxins are known to induce the expression of various pro-inflammatory cytokines following a tropical application in rats [25] and increased the expression of IL-12 and TNF-α with a corresponding decrease in the expression of IL-1β in mouse peritoneal macrophages and lymph node T cells [26]. In addition, in previous findings this toxin has been observed to increase the expression of IL-2 and reduce IFN-γ expression in pigs [27]. T-2 toxin is known to induce apoptosis in lymphoid and hematopoietic tissues, intestinal crypt epithelial cells, spleen as well as the brain [2831].

With this background, the present study is to ascertain T-2 toxin-induced pathology in goats. In addition, the study aims at the assessment of expression of various HSPs as oxidative damage indicators, pro-apoptotic genes and pro-inflammatory cytokines in goats in order to understand the molecular mechanism of T-2 toxicity.

Materials and methods

Production and analysis of T-2 toxin

Pure culture of Fusarium sporotrichioides var. sporotrichioides (MTCC-1894) was procured from the Institute of Microbial Technology (IMTC), Chandigarh, India. T-2 mycotoxin was produced by fermentation of maize and wheat mixture as per the method described in AOAC international [32]. The generated toxin was analyzed and quantified by thin layer chromatography and spectrophotometry at the Animal Feed Analytical and Quality Control Laboratory (AFAQCL), Veterinary College and Research Institute, Namakkal, Tamil Nadu, India.

Experimental animals

A total of eighteen goats (Barbari breed) between 2–3 months age were used in this study. All the procedures in the trial were carried out under strict guidelines with the recommendations and prior approval by the Institute's Animal Ethics committee (IAEC) of ICAR-Central Institute for Research on Goats (CIRG), Mathura and Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), New Delhi (India) (number: 207\GO/cb/2000/CPCSEA dt:1.6.2000). The animals were examined and treated for internal and external parasites and maintained under standard conditions. After an acclimatization period of one week, the toxin was administered orally by mixing with the feed along with a control group. These animals were kept under optimum housing conditions and provided ad libitum feed and fresh drinking water. After the trial, the goats were euthanized by intravenous administration of 20% sodium pentobarbital into the jugular vein with minimal pain and suffering. During the course of the experiment, no animals died prior to euthanization [33].

Experimental diet

Feed pellets as well as ground feed were procured from the Feed Processing Unit, C.I.R.G, Makhdoom and were tested negative for the presence of mycotoxin contamination (Aflatoxin B1, Ochratoxin A, citrinin and T-2 toxin) The inoculum containing known amounts of T-2 toxin was added and thoroughly mixed with the basal ration in proportion to deliver the set dosage (10 and 20 ppm). From the diet, aliquots were taken and quantified by TLC and spectrophotometric analysis for assuring the correct concentration.

Experimental design

Juvenile goats were randomly divided into three groups consisting of six animals each and weighed to give an average initial mean body weight and tags were marked for identification. Feed containing T-2 toxin levels of 10 ppm and 20 ppm (mg/kg of feed) were prepared. The details of the experimental design are given in (Table 1).

Table 1. Experimental design of T-2 toxicosis in goats.

Details Group I (10 ppm) Group II (20 ppm) Group III (control)
Age of goats (kids) 2–3 months 2–3 months 2–3 months
No. of animals 06 06 06
Duration of the experiment 30 days 30 days 30 days
Dose of toxin 10 ppm (mg/kg of feed) 20 ppm (mg/kg of feed) Toxin free feed
Route of administration Oral (Mixed with feed) Oral (Mixed with feed) Oral (Feed free from mycotoxins)
Sacrifice intervals 15th and 30th day of the trial
No. of animals sacrificed at each interval 03 03 03

Parameters studied

a. Clinical signs

Careful observation of the animals in the study was conducted to evaluate the development of any clinical conditions or mortality. Body weight of individual animal was recorded on day 0, 5, 10, 15 and 20, 25 and 30 post-treatment in all the groups.

b. Hematology

Blood was drawn from the jugular vein from all the goats of different groups on day 0, 5, 10, 15 and 20, 25 and 30 in vials containing Ethylene diamine tetra acetate (1mg/ml of blood). Hemoglobin concentration (Hb), packed cell volume (PCV), total erythrocyte count (TEC), total leukocyte counts (TLC), differential leukocyte counts (DLC) and total thrombocyte count (TTC) were carried out by automatic blood analyzer(Sysmex XE-5000 hematology analyzer, Sysmex, Kobe, Japan) as per the manufacturer’s instructions.

c. Estimation of oxidative stress enzymes

The method to evaluate oxidative stress were TBRS activity (Thiobarbituric acid ‘TBA’ method), Superoxide dismutase (SOD) and catalase in liver, kidney, small intestine, spleen, mesenteric lymph node (MLN) and brain tissue homogenates for all the animals on 15th and 30th day according to the method described by Shivasharanappa [34]

Pathomorphological studies

Gross pathology

Post euthanization procedure on the 15th and 30th day, the visceral organs was carefully evaluated for the development of lesions. The weights of these organs were also tabulated as relative organ weight.

Histopathology

Pieces of the tissues from liver, intestines, MLN, kidneys, spleen and brain (less than 5 mm thickness) were collected and fixed in 10% neutral buffered formalin solution. After 48 hours of fixation, the tissues were processed and stained by hematoxylin and eosin method [35].

Ultra-structural changes

Approximately 1-2mm sized tissue pieces from liver, kidney, small intestine and brain were collected and fixed in chilled 2.5% glutaraldehyde for 6–8 h at 4o C. Tissue samples were washed twice (20 min each) in chilled 0.1 M phosphate buffer and then fixed in 1% osmium tetroxide for 2 h at 4o C. The tissues were rinsed thrice in 0.1 M phosphate buffer at 4o C and dehydrated in ascending grades of acetone (30%, 50%, 70%, 90%, 100% and dry acetone) for 15 min each. The tissue samples were cleared twice in toluene at room temperature and infiltrated in toluene and resin in the ratio 3:1, 2:2, 1:3 and pure resin for one hour. The tissue samples were embedded in Araldehyte media and kept at 37°C for 24 h and then incubated at 45o C for 2 days for polymerization. The polymerized blocks were trimmed and ultra-sections of 500 nm were cut employing ultra tome microscope (Ultra-cut UCT, Leica, Germany), mounted on copper grids and stained with uranyl acetate [36] and followed by lead citrate[37].The sections were washed and allowed to dry on a filter paper in a covered Petri dish. The grids were mounted to be viewed under the electron microscope (Philips, CM-10, Holland). Processing, section cutting, staining and examination of grids were carried out at High Security Animal Disease Laboratory (HSADL), Bhopal. India.

Apoptosis by TUNEL (TdT-mediated dUTP Nick-End Labeling) assay

Apoptosis was studied using Dead End Colorimetric TUNEL System (Promega) assay in liver, intestines, kidney, spleen, mesenteric LN and brain. After the staining, the TUNEL-positive cells were counted under the scanning confocal microscope to evaluate apoptosis of the cells.

RNA isolation and cDNA synthesis

The apoptosis genes such as Bcl-2, Bax and caspase-3, Heat shock protein (HSP) genes viz. HSP-72, 90 and 27 and pro-inflammatory genes (IL-1, IL-6, TNF-α) in different tissues such as liver, intestine, kidney, spleen, mesenteric LN and brain were used to isolate RNA. RNeasy Lipid Mini Kit (Qiagen, Hilden, Germany) was used to extract total RNA from the tissue samples. The concentration and quality was evaluated using Nano Drop 2000 spectrophotometer (Thermo Fischer Scientific Inc, Carlsbad, CA, USA). Complementary DNA (cDNA) synthesis was performed using the Superscript First Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA, USA). PCR amplification was carried out using the cycling conditions as follows: an initial 10 min activation and denaturation step at 95°C, followed by 40 cycles of 15s at 95°C and 30 s, 72°C for 1 min and finally 72°C for 5 min.

Differential expression of HSPs (HSP-72, 90 and 27), apoptosis (Bcl-2, Bax and Caspase 3) genes and pro-inflammatory cytokines (IL-1, IL-6 and TNF-α) using qRT-PCR

The reaction mixture containing 1X SYBR®Green (PE Applied Biosystems), 5mM MgCl2, buffer, 0.5μM primer, 1 U Taq, 0.3 mM dNTP and 50 ng cDNA was subjected to the PCR reaction using the cycler conditions mentioned above. Real-time RT-PCR amplifications were performed in an ABI-Prism 7000 Sequence Detection System (PE Applied Biosystems). The levels of gene expression were determined using the comparative Ct method. A normalization factor was used to determine the expression level of each gene in each sample against the control. All target gene transcriptions were expressed as n-fold difference relative to the control.

Statistical analysis

The data was statistically analyzed using analysis of variance (ANOVA) and significance levels were kept at 1 and 0.5 percent. For the analysis of qPCR products, the data obtained were analyzed by using the 2–(ΔΔCt) method. Finally, the mean relative expression for each group was statistically analyzed by one way ANOVA [least significance difference (LSD) and Duncan’s Test] for ‘T’ distribution (P value) using SPSS (21.0) Software.

Results

Clinical signs

The administration of the toxin to goats exhibited varying degree of pathological symptoms including weakness, lethargy, growth retardation, feed refusal and reduced movement. However, diarrhea was the most consistent symptom observed right from the 20th day post treatment in both the toxin treated groups. 4 goats from group I and 6 from group II showed diarrhea with soiled hindquarters. Goats from the group III remained void of these clinical symptoms. Also, in group II extensive pathological lesions were seen in the lumen and abomasum of the GI system. Further, ruminal epithelium exhibited peeling whereas abomasum showed congestion in response to the toxin treatment on 15th and 30th day. However, no significant histological changes were seen in group I on 15th and 30th day.

Body weight

The body weights recorded at 0, 5, 10, 15, 20, 25 and 30th day post feeding of the toxin are given in (Table 2). 15 days onwards, the mean body weights in the toxin fed groups exhibited lower weight-gain than in the control group, which were found to be dose- and duration- dependent. On 15th and 30th day, group II showed significantly lower body weight-gain when compared to other groups. In the control group, there was a progressive body weight-gain with respect to time contrary to those in the toxin fed groups. No mortality was observed during the experimental period.

Table 2. Effect of T-2 toxin on body weights of kids fed with 10 ppm and 20 ppm dose at different intervals.

Days Body weight (kg)
Group I (10ppm) Group II (20ppm) Group III (Control)
0 7.05±0.34aA 7.08±0.86aA 6.79±0.49aA
5 7.09±0.42 abA 6.79±0.44 aA 6.62±0.27 bA
10 7.43±0.28 aA 6.29±0.47 aB 7.47±0.19 aA
15 7.16±0.42 abA 5.92±0.48 aB 7.25±0.19 abA
20 6.280±0.1 cbaA 5.89±0.62 aA 7.36±0.12 aA
25 6.02±0.39 cbAB 5.56±0.52 aB 7.73±0.06 aA
30 5.65±0.27 cB 5.21±0.52 aB 7.73±0.1 aA

Means bearing at least one common superscript (a,b,c) do not differ significantly between groups (p<0.05). Means bearing at least one common superscript (A, B) do not differ significantly between days (p<0.05). FD = 1.49, FG = 14.91**, FGD = 1.89, FD = effect within days (D), FG = effect within groups (G), FDG = interaction within days and groups *<0.05, **<0.01

Haematological changes

The hematological parameters are tabulated in (Table 3). There was a significant reduction in hemoglobin, total leukocyte counts and total thrombocyte counts in toxin treated groups in comparison with those of the control group in a dose- and time-dependent manner. There was a significant reduction in total platelet count particularly in group II on the 25th day.

Table 3. Effect of T-2 toxin on hemoglobin (Hb), total leukocyte counts (TLC) and total thrombocyte count (TTC) at different intervals in goats fed with 10 ppm and 20 ppm of toxin.

Parameters GROUP 5th 10th 15th 20th 25th 30th F value
Hb (g/dl) I 07.62±0.37bc 08.06±0.65c 07.87±0.29c 07.73±0.68bc 5.32±0.14abB 5.01±0.03aB FD = 23.92**
II 07.43±0.29b 07.40±0.21b 07.50±0.45b 06.33±0.24b 4.21±0.03aA 4.06±0.02aA FG = 5.34**
Control 07.65±0.24a 07.48±0.23a 07.20±0.21a 07.07±0.18a 7.01±0.04aC 6.98±0.08aC FDG = 4.61**
TLC (x103/μl) I 07.00±0.29 08.82±0.56A 06.80±0.98 07.51±0.23B 5.56±0.23aAB 4.17±0.32aA FD = 10.68**
II 07.98±0.47c 06.43±0.18bcB 07.43±0.33c 04.59±0.19abA 4.53±0.61abA 3.67±0.18aA FG = 8.47**
Control 06.75±0.52a 06.50±0.28aB 06.03±0.08a 07.93±0.57bB 6.98±0.86abB 7.05±0.09abB FDG = 11.7**
TTC (x103/μl) I 357.30±38.5a 402.80±31.6a 344.20±24.3a 309.20±7.19aB 265.50±6.54aB 253.3±5.43aB FD = 5.67**
II 371.20±44.8ab 415.90±29.0b 368.40±54.1ab 225.30±11.7abA 199.10±3.23aA 176.30±6.65aA FG = 11.43**
Control 399.1±39.3a 382.70±33.3a 476.30±5.9a 396.50±.22aC 383.0±6.65aC 392.50±4.56aC FDG = 1.7

The data were analyzed using two way-ANOVA and Tukey’s Post hoc test which is incorporated in SPSS statistical software. Superscripts A, B and C shows differences in columns and a, b, c, d in rows. Mean bearing at least one common superscript didn’t show any difference. FD = effect within days (D), FG = effect within groups (G), FDG = interaction within days and groups *<0.05, **<0.01.

Oxidative stress enzymes

The antioxidant enzyme values are tabulated in (Table 4). The antioxidant enzymes were remarkably enhanced in the tissue homogenates around the 30th day suggesting its time dependency. Hepatic SOD and catalase were notably increased in group II than in group I whereas hepatic MDA levels were higher in group I even from the 15th day onwards indicating its toxicity on the liver at lower doses also. Likewise, the intestinal SOD and catalase levels were higher in group II on 3th day indicating a severe injury to the cells of the intestine. In addition, in the MLN and spleen the MDA concentration increased remarkably whereas only catalase and SOD increased in the spleen in group II. Also, in the brain levels of all the enzymes tested were increased with no notable difference between the two groups.

Table 4. Effect of T-2 toxin on oxidative stress enzymes in various organs.

Organ Enzymes (Days) Groups F value
10ppm (Group I) 20ppm (Group II) Control (III)
Liver CAT (103/U) 15 1756.50±3.15aB 1684.2±9.45bB 1629.2±1.95cB FG = 226.4**
FD = 305.7**
FDG = 88.85**
30 1843.90±5.70bA 1939.4±17.8aA 1659.3±1.9cA
SOD (U/g) 15 77.10±1.25bB 86.6±2.30aB 73.2±0.55bB FG = 72.32**
30 106.60±4.05aA 118.8±1.6aA 82.9±0.80bA FD = 187.0**
FDG = 17.0**
LPO (nM) 15 56.00±2.65aB 63.4±4.15a 33.9±1.4b FG = 90.9**
30 78.80±4.40aA 80.9±4.15a 29.8±0.5b FD = 20.2**
FDG = 9.45*
Intestine CAT (103/U) 15 1578.30±4.95bB 1804.6±5.8aB 1436.3±2.4cB FG = 566.0**
30 2037.70±6.5aA 1949.8±24.8bA 1619.3±4cA FD = 854.9**
FDG = 121.8**
SOD (U/g) 15 85.90±0.35bB 110.8±1.55aB 76.5±0.45c FG = 422.6**
30 106.30±2.05bA 134.4±2.15aA 78.6±1.65c FD = 123.5**
FDG = 30.9**
LPO (nM) 15 57.40±3.10bB 96.3±3.6a 48.1±2.55b FG = 206.5**
30 98.40±2.0aA 113.7±4.0a 41.7±1.9b FD = 51.0**
FDG = 32.1**
MLN CAT (103/U) 15 1602.80±9.4bB 1649±4.65aB 1366.1±3.4cB FG = 1009.6**
30 1665.20±8.7bA 1751.8±6.05aA 1482.4±3.2cA FD = 331.1**
FDG = 10.5*
SOD (U/g) 15 74.80±2.45aB 78.6±0.85aA 45.6±2.15b FG = 266.5**
30 86.0±1.55aA 70.5±1.05bB 52.2±0.9c FD = 11.3*
FDG = 24.9**
LPO (nM) 15 56.4±1.45B 58.6±1.05B 50.9±3.7 FG = 30.3**
30 70.4±2.45aA 79.4±3.45aA 50.3±1.35b FD = 35.0**
FDG = 8.7*
Kidneys CAT (103/U) 15 1717.60±15.20b 1789.4±7.2aA 1571.6±2.4bA FG = 78.8**
30 1717.00±6.40a 1651.5±3.8bB 1590.6±1.35cB FD = 150.7**
FDG = 41.9**
SOD (U/g) 15 74.80±2.45b 116.4±3.00a 71.2±1.1c FG = 292.6**
30 84.60±2.25b 135.3±3.5a 66.5±2.1c FD = 15.6**
FDG = 11.7**
LPO (nM) 15 60.50±3.9 61.4±2.5 49.6±4.35 FG = 16.95**
30 73.50±2.55 61.9±4.35 48.1±6.2 FD = 0.8
FDG = 3.88
Spleen CAT (103/U) 15 1431.20±1.65cB 1766.3±4.45aB 1573.8±2.5bB FG = 1904.4**
FD = 944.3**
FDG = 197.6**
30 1642.80±3.55bA 1829.3±8.55aA 1630.2±1.4bA
SOD (U/g) 15 67.30±0.95bB 81.3±1.95a 56.9±2.6b FG = 78.7**
30 73.40±1.00bA 89.3±0.95a 65.3±3.05b FD = 22.5**
FDG = 0.22
LPO (nM) 15 70.40±2.75b 91.4±1.75aB 74.9±2.75b FG = 65.99**
30 74.40±4.80b 122.2±3.8aA 81.25±2.05b FD = 27.5**
FDG = 10.6*
Brain CAT (103/U) 15 1626.60±12.90bB 1717.7±5.6aB 1564.9±2.75cA FG = 1675.2**
FD = 9.84*
30 1717.50±5.80bA 1909.7±1.4aA 1329.2±1.6cB FDG = 610**
SOD (U/g) 15 72.40±0.75bB 94.2±1.00a 65.1±2.2b FG = 115.9**
30 82.20±0.70abA 88.30±1.05a 74.2±2.1b FD = 14.2**
FDG = 19.23*
LPO (nM) 15 79.90±3.25b 99.40±1.65a 77.9±3.8b FG = 33.9**
30 82.40±5.40b 108.30±2.25a 79.3±2.45b FD = 2.7
FDG = 0.81

The data were analysed using one way ANOVA, two way ANOVA and independent t test wherever applicable. Superscripts A, B and C shows differences in columns and a, b, c, d in rows. Mean bearing at least one common superscript didn’t show any difference. FD = effect within days (D), FG = effect within groups (G), FDG = interaction within days and groups *<0.05, **<0.01. CAT (103/U)—Catalase, SOD-Superoxide Dismutase, LPO-lipid peroxidation (nM of MDA/g of tissue).

Pathomorphological changes

Gross pathological alterations

Group I. Overall, remarkable changes were found in most visceral organs except in intestine, liver and spleen. The relative organ weights of the liver and MLN increased. There was a marked enlargement of the liver and diffused congestion with distended gall bladder on the 30th day of the trial. All the segments of the intestine showed diffused congestion and haemorrhages with pasty mucoid contents. Kidneys at 15th and 30th day showed paler cortex. The other organs such as abomasum, rumen, lungs and heart did not exhibit any remarkable gross changes.

Group II. At the 30th day post toxin exposure, liver was found enlarged with rounded edges, diffused congestion and distended gall bladder. The intestine and liver were the most affected organs in this group. Mesenteric lymph nodes were enlarged and oedematous and the brain revealed meningeal vessels engorgement.

Histological alterations

Extent, severity and type of lesions differed among the groups based on the type of organ involved, dose and duration of toxin feeding. Liver and intestines were the most severely affected organs exhibiting remarkable histological alterations. These lesions were broadly classified as vascular and cellular changes in all the organs. Overall scoring of histological lesions was also done for the other organs mentioned above. The histopathological changes observed in various organs of the different groups are given in (Table 5).

Table 5. T-2 toxin induced histological alterations (score card) in different organs of goats on 15th and 30th days fed with 10ppm and 20ppm dose.

Organs Lesions 15th day At 30th day
Groups Groups
I II III I II III
Liver Vascular engorgement/sinusoidal congestion - 1M/3 1m/3 1m/3 3M/3 1m/3
Hepatocyte degeneration/coagulative necrosis 1M/3 2M/3 0/3 3M/3 3S/3 1m/3
Centrio-lobular degeneration/ coagulative necrosis 1m/3 3S/3 0/3 2S/3 3S/3 0/3
Hepatocyte vacuolation 1M/3 1M/3 0/3 1m/3 1S/3 0/3
Bile duct hyperplasia/thickening - 3S/3 0/3 2S/3 3S/3 0/3
Periductular connective tissue proliferation/thickening/fibrosis - 2S/3 0/3 - 3S/3 0/3
Total score 05 32 01 20 48 02
Intestine Vascular engorgement/congestion 1M/3 2M/3 1m/3 1m/3 3S/3 0/3
Crypt epithelial hyperplasia 1M/3 2M/3 1m/3 3S/3 3S/3 1m/3
Necrosis of cryptic cells - 2S/3 0/3 3S/3 3S/3 0/3
Infiltration of lymphocytes in lamina propria - 2m/3 1m/3 3M/3 3S/3 1M/3
Necrosis of lymphocytes in lamina propria - 2S/3 0/3 2S/3 3S/3 0/3
Giant crypts/fusion of crypts - 1m/3 0/3 - 3M/3 0/3
Total score 04 23 03 31 51 03
MLN Vascular engorgement - - 0/3 - 1m/3 0/3
Lymphoid depletion - 1m/3 0/3 1S/3 2M/3 0/3
Lymphocyte necrosis/nuclear fragmentation/apoptosis 1m/3 2S/3 0/3 3S/3 3S/3 0/3
Total score 01 07 0 12 14 0
Kidneys Vascular congestion/hemorrhages 1m/3 2m/3 0/3 2m/3 - 0/3
Interstitial edema/plasma leakage - 1m/3 0/3 1m/3 1m/3 0/3
Tubular degeneration/necrosis 1M/3 3S/3 0/3 3S/3 3S/3 0/3
Total score 03 12 0 12 10 0
Spleen Vascular engorgement 1m/3 2m/3 0/3 2m/3 1S/3 0/3
Lymphoid depletion - 2M/3 0/3 2S/3 2S/3 0/3
Lymphocyte necrosis/apoptosis - 2M/3 0/3 2S/3 3S/3 0/3
Epitheloid cell reaction/Macrophage infiltration - 1M/3 0/3 - 3S/3 0/3
Total score 01 12 0 20 27 0
Brain Vascular engorgement - - 0/3 2M/3 2M/3 1m/3
Neuronal degeneration - 1m/3 0/3 1M/3 2M/3 1m/3
Focal/diffuse gliosis - 1m/3 0/3 2M/3 1M/3 0/3
Total score - 02 0 08 08 02

Group I-10 ppm, II-20 ppm and III- Control; Scoring–Number of organs with lesions/Number of organs examined per group; m- mild, M-moderate, S-severe. Score: m = 01, M = 02, S = 03.

Liver

Group I. Varying degree of degenerative and necrotic lesions were seen in the hepatic parenchyma. Hepatocytes on the 15th day exhibited swollen and granular cytoplasm. Bi-nucleated hepatocytes having karyomegaly were observed at various instances whereas a few cells also exhibited degeneration and necrosis of the eosinophilic granular cytoplasm and nuclear condensation (Fig 1).

Fig 1. Liver (group 1, 15 days): epithelial hyperplasia with bile ducts having degeneration of hepatocytes.

Fig 1

HE 400X.

30th day post toxin treatment showed extensive lesions characterized by degeneration of the hepatocytes towards the portal triad. Hepatic artery and portal veins along with the other blood vessels were swollen and dilated. Hyperplasia of the bile duct was also visible along with cell necrosis consistently present on the 30th day. In one case, diffused type of coagulative necrosis of hepatocytes (individual cell necrosis) with dark pyknotic nucleus was seen scattered in the parenchyma along with diffuse fatty changes in large number of hepatocytes (Fig 2).

Fig 2. Liver (group 1, 30 days): individual cell necrosis with dark pyknotic nucleus in the parenchyma with diffuses fatty changes of hepatocytes.

Fig 2

HE 100X.

Group II. This group exhibited the maximum severity of lesions of the hepatocytes right from the 15th day showing engorgement and sinusoidal congestion in all the experimental animals. Visible centrilobular necrosis was found along with hypertrophy of the bile duct and dead cell debris accumulation in the lumen leading to peri-billiary fibrosis (Fig 3).

Fig 3. Liver (group 2, 15 days): Hypertrophy peri-billiary hyperplasia/fibrosis with bile ducts having cell debris and diffuse centrilobular necrosis of hepatocytes.

Fig 3

HE 100X.

By the 30th day, all these features were observed in all the animals in the study. Extensive cell necrosis was seen with distinct and dark nucleus as well as eosinophilic cytoplasm called ‘Ghost hepatocytes’ (Fig 4).

Fig 4. Liver (group 2, 30 days): Hepatocytes showing distinct dark nucleus and homogeneous deep eosinophilic cytoplasm called as ‘Ghost hepatocytes’.

Fig 4

HE 400X.

Intestines

Group I. The segments of the intestine namely duodenum, ilium and jejunum showed characteristic lesions led by cellular and vascular alteration by 15th day post toxin induction. Hyperplasia of the crypt epithelium was moderate whereas less evident lymphatic infiltrations were seen in the lamina propria with scarce vascular swelling in the mucosa (Fig 5).

Fig 5. Intestines (group 1, 15 days): Lamina propria showing diffusely infiltrated with necrotic lymphocytes, nuclear pyknosis and fragmentation.

Fig 5

HE 100X.

Studies on the 30th day revealed the progression of these lesions and necrosis to severity. The cryptic cell hyperplasia led to necrosis of the epithelial cells of the crypt with infiltrated lamina propria exhibiting necrotic variations like nuclear pyknosis and fragmentation. The graded score for the crypt epithelial necrosis was significantly higher (3.0 ± 0.00) than on the 15th day (1.7 ± 0.33) and also than that in controls (0.3 3± 0.33) whereas that of the necrotic lymphocytes in villous epithelium, Peyer’s patches and lamina propria did not vary between groups.

Group II. Lesions were severe on both 15th and 30th days after toxin administration in this group. Similar vascular engorgement in the lamina propria, infiltration of the lymphoid cells like macrophages, lymphocytes and plasma cells in the inter-cryptic spaces and cell necrosis were observed on the 15th day (Fig 6).

Fig 6. Intestines (group 2, 15 days): Lamina propria showing depletion/lymphocytolysis in Peyer’s patches.

Fig 6

HE 400X.

They were progressive and became severe by the 30th day showing lymphocytolysis or depletion in the Peyer’s patches along with necrotic fragmentation of nucleus and aggregation of the lymphoid cells in the lamina propria. In addition, the epithelial cells were diffused showing fragmented nuclei, infiltration and necrosis of the lymphocytes and disruption of the basement membrane were the visible features on the 30th day (Fig 7). The dead eosinophilic debris replaced the necrosed crypt epithelium with complete loss of cryptic architecture. The graded mean score of necrotic cells in lamina propria on the 30th day (2.7±0.33) was significantly higher when compared with that on the 15th day (1.33±0.66) and also than that in controls. But the score of necrosis in cryptic cells, villous epithelium and Peyer’s patches did not differ significantly between days (Table 6).

Fig 7. Intestines (group 2, 30 days): Crypts in lamina propria showing diffuse epithelial necrosis with fragmentation of nuclei, disruption of BM and necrosis of lymphocytes.

Fig 7

HE 400X.

Table 6. Graded score of necrotic cells in intestine in response to T-2 Toxin @ 10 ppm and 20 ppm on 15th and 30th day of toxicosis in goats.
Organ Days Crypt epithelium Lamina propria Villus epithelium Peyer’s patches
I II III I II III I II III I II III
Intestine 15th 1.7±0.33bB 3.0±0.00a 0.33±0.33c 1.0±0.57 1.33±0.66B 0.7±0.33 1.0±0.57 0.7±0.33 0.33±0.33 1.0±0.57 1.33±0.33 0.33±0.33
30th 3.0±0.00aA 2.7±0.33a 1.0±0.57b 1.7±0.33b 2.7±0.33aA 0.33±0.22c 1.0±0.57 0.7±0.33 0.33±0.33 2.0±0.57a 2.33±0.66a 0.7±0.66b

Group I-10 ppm, II-20 ppm and III- Control, Score: 1-mild necrotic cells, 2-moderate necrotic cells, 3- Sever necrotic cells. The data were analysed using one way and two way ANOVA. Mean bearing at least one common superscript did not differ between days and groups. Each part of intestine analyzed separately. The level of significance was kept at 0.05.

Mesenteric lymph nodes

Group I. The histological changes were time-dependent, which means that the microscopic changes on the 15th day were less intense when compared to that of the 30th day. On the 15th day, mild depletion of the lymphoid follicles were seen with a scattered necrosis in the lymphoid cells whereas the changes on the 30th day included a widespread reduction in the cortical follicle and necrosis of the lymphocytes (Fig 8).

Fig 8. Mesenteric lymph nodes (group 1, 30 days): Widespread depletion in cortical follicles with diffuse necrosis of lymphocytes/lymphocytolysis.

Fig 8

HE 400X.

Group II. In the higher dosage treated group on 15th day, inter-follicular space exhibited moderate vascular swelling. In two of the animals, in the cortical zone infiltration of the polygonal cells was observed coupled with foamy cytoplasm similar to the epithelioid cells and macrophages. These changes progressed to severity on the 30th day showing severe depletion of the lymphoid cells and lymphocytolysis (Fig 9). These changes were characterized by scattered necrotic cells of the lymphocytes and macrophages in the lymphoid follicle of the cortex rendering it a starry sky appearance. All the three cases examined revealed signs of lymphoid depletion and infiltration in the polygonal cells to a large extent through the entire paracortical zone resembling epithelioid cells and macrophages. The graded score of necrotic cells was significantly higher in group II on 15th day (2.7±0.33) than in group I (1.00±0.00) and also than that in controls (0.7±0.33).

Fig 9. Mesenteric lymph nodes (group 2, 30 days): Lymphoid depletion and infiltration of large polygonal epithelioid cells and macrophages.

Fig 9

HE 400X.

Kidneys

Group I. The histological changes in the kidney on 15th day were not remarkable but the pathology progressed over time. On the 30th day, features such as vascular engorgement, degeneration of the PCT and DCT with intact glomeruli were visible. Epithelial cells of the DCT showed detachment along with the degeneration of the vacuoles and occurrence of granular pink matter in the lumen. Similar to the other organs, the lesion progressed to necrosis in the kidney as well, with degeneration of the PCT and DCT along with the epithelial cell accumulation (Fig 10).

Fig 10. Kidney (group 1, 30 days): Epithelial cells of DCT showing detachment, degeneration of vacuoles and occurrence of granular pink matter in the lumen.

Fig 10

HE 400X.

Group II. Characteristic epithelial cell damage showing eosinophilic granular cytoplasm was seen on the 15th day. Epithelial cells were swollen with haemorrhages in the interstitial cells in two of the cases. Likewise, complete epithelial destruction leading to its accumulation in the lumen was seen on the 30th which included loss of nuclei and brush border (Fig 11).

Fig 11. Kidney (group 2, 30 days): Degeneration of PCT and DCT showing loss of nuclei and brush borders.

Fig 11

HE 400X.

Spleen

Group I. The parenchyma cells of the spleen exhibited observable red pulp because of the engorgement of the sinusoid. Lymphocytes were slightly depleted in the marginal zone of the pulp. On the 30th day however, moderate depletion of the follicles and necrosis of the lymphocytes in the spleen was seen around the central artery (Fig 12). The graded mean score of lymphoid depletion (2.7±0.33) and necrosis (2.00±0.57) on 30th day was significantly higher than that in controls (0.33±0.33). Although there was little difference in the score between intervals in the toxin treated groups.

Fig 12. Spleen (group 1, 30 days): Follicles showing depletion and necrosis of lymphocytes around the central artery.

Fig 12

HE 400X.

Group II. On the contrary to group I, group II showed severe depletion in the lymphoid cells right from the day 15 around the marginal and parafollicular zones. Two of the cases exhibited moderate necrosis also. Conversely, on the 30th day there was severe depletion in the lymphoid cells, thickening of the capsules and congestion in the sinusoid. It was also notably that prominent epithelioid cells reacted in the white pulp leading to lymphocytolysis. These cells were pleomorphic, large resembling macrophages in white pulp (Fig 13). Graded score of lymphoid depletion and necrosis of lymphoid cells was significantly higher on 15th and 30th day when compared to that in controls. There was no difference between intervals but higher score was recorded in toxicated groups than in the control group (Table 7).

Fig 13. Spleen (group 2, 30 days): Epithelioid cells reactions in the white pulp leading to lymphocytolysis.

Fig 13

HE 400X.

Table 7. Graded score lymphoid depletion and necrosis of lymphoid cells (lymphocytolysis) in response to T-2 toxin @ 10 ppm and 20 ppm on 15th and 30th day.
Organ Days Lymphoid depletion Lymphoid necrosis (lymphocytolysis)
I II III I II III
Spleen 15th 1.33±0.33b 3.0±0.00a 0.7±0.33c 1.0±0.57b 2.7±0.33a 0.7±0.33b
30th 2.7±0.33a 2.7±0.33a 0.33±0.33b 2.0±0.57a 3.0±0.00a 0.33±0.33b
MLN 15th 1.0±0.00b 2.7±0.33a 0.7±0.33b 1.33±0.7b 2.7±0.33a 0.33±0.33c
30th 2.0±0.57a 3.0±0.00a 0.7±0.33b 2.33±0.7a 3.0±0.00a 0.33±0.33b
Peyer’s patches 15th 1.0±0.00a 1.7±0.33a 0.33±0.33b 0.7±0.33bB 1.7±0.33aB 0.33±0.33b
30th 2.7±0.33a 2.7±0.33a 0.33±0.33b 2.0±0.57aA 3.0±0.00aA 0.7±0.33b

Group I-10ppm, II-20ppm and III- Control, Score: 1-mild depletion, 2-moderate depletion, 3- severe depletion. 1-mild necrotic cells, 2-moderate necrotic cells, 3- severe necrotic cells. The data were analysed using one way and two way ANOVA. Mean bearing at least one common superscript did not differ between days and groups. Each organ and parameter analyzed separately between groups and days. The level of significance was kept at 0.05.

Brain

Group I. On 15th day, mild focal glial cell reaction was visible containing a few microglia and oligodendroglia with occasional neurons exhibiting shrinkage and degeneration. On 30th day, vascular changes such as micro capillaries engorgement and congestion in the cerebral cortex and thalamic region were observed in two cases. These cases also showed focal glial cell reaction with degeneration of cortical neurons having distinct dark nucleus.

Group II. On 30th day, neurons showed shrinkage and degeneration with eosinophilic cytoplasm. Dead neurons were surrounded by microglia and oligodendroglia cells indicating satellitosis and neuronophagia (Fig 14). Degeneration of Purkinje cells in cerebellum which was characterized by the loss of nucleus and homogenous amorphous cytoplasm was evident.

Fig 14. Brain (group 2, 30 days): Neurons showing shrinkage and degeneration with eosinophilic cytoplasm indicating satellitosis.

Fig 14

HE 400X.

Ultrastructural changes

Liver

Numerous vacuolation was observed close to the nuclei in the liver cells. These nuclei exhibited aggregation and margination of the heterochromatin with indistinct nuclear membrane. Mitochondria also showed loss of cristae and dissolution of the inner matrix and looked like an empty vacuole in group II after 30 days (Fig 15). While the cross sections in group II after 30 days showed severe hyperplasticity of the collagen (Fig 16).

Fig 15. Liver (group 2, 30 days): Mitochondrial degeneration with loss of cristae and formation of empty spaces in the cytoplasm of hepatocytes.

Fig 15

Uranyl acetate and lead citrate 200X.

Fig 16. Liver (group 2, 30 days): Hyperplasticity in the collagen fibers of liver.

Fig 16

Uranyl acetate and lead citrate 1000X.

Small intestine

Heterochromatin exhibited condensation, margination and clumping with indistinct nuclear membrane. Enterocytes showed consistent variations in both the groups on the 30th day. Degenerated and pleomorphic mitochondria with loss of cristae and dissolution of inner matrix was also observed (Fig 17).

Fig 17. Small intestine (group 2, 30 days): Heterochromatin showing condensation, margination and clumping with indistinct nuclear membrane in enterocytes.

Fig 17

Uranyl acetate and lead citrate 1000X.

Kidneys

Mitochondria and nucleus showed extensive degeneration on the 30th day. Epithelial cells were also affected showing loss of cristae leading to empty space and rendering the mitochondria pleomorphic. Condensation and margination of heterochromatin with indistinct nuclear membrane were also evident as shown in Fig 18 in the higher dose group i.e. group II after 30 days ().

Fig 18. Kidney (group 2, 30 days): Epithelial cells showing loss of cristae leading to mitochondria pleomorphic.

Fig 18

Uranyl acetate and lead citrate 500X.

Brain

Neuronal degeneration was the most consistent finding noticed in group II on 30th day. It was characterized by presence of circular, whirling dark structures in the brain (Fig 19).

Fig 19. Brain (group 2, 30 days): Degeneration of neurons by formation of circular, whirling dark structures called as myelin figures.

Fig 19

Uranyl acetate and lead citrate 1000X.

Apoptotic changes

Apoptosis was detected in hepatocytes around the central vein and portal triad in group I after 30 days (Fig 20). Within the intestine in group I after 30 days, apoptosis was detected in cryptic epithelial cells of the small intestine (Fig 21). Whereas in group II after 30 days, Peyer’s patches of which the cryptic epithelial cells showed extensive apoptotic bodies (Fig 22) and within the MLN was also extensive apoptosis was witnessed in the lymphoid follicles (Fig 23). Within the kidney tissues, PCT and DCT epithelial cells exhibited apoptotic changes in group II after 30 days (Fig 24). The white pulp of the spleen also exhibited extensive apoptotic lymphoid cells in group II after 30 days (Fig 25). Among all the treated groups, group I and group II showed significantly higher score on the 30th day than on the 15th day when compared to controls. However, brain did not reveal the presence of any apoptotic cells in both the treatment as well as control groups. Mean score of TUNEL positive apoptotic cells in liver, intestine, MLN, Kidneys, spleen and brain on 15th and 30th day in both the groups were counted in high power field (x400) and presented in Table 8.

Fig 20. Liver (group 1, 30 days): Apoptosis in hepatocytes around central vein and portal triad.

Fig 20

DAB 400X.

Fig 21. Small intestine (group 1, 30 days): Apoptosis in cryptic epithelial cells of the small intestine.

Fig 21

DAB 400X.

Fig 22. Small intestine (group 2, 30 days): Peyer’s patches in intestine showing apoptotic lymphocytes.

Fig 22

DAB 400X.

Fig 23. Mesenteric lymph nodes (group 2, 30 days): Apoptotic lymphocytes in the follicles of MLN.

Fig 23

DAB 400X.

Fig 24. Kidney (group 2, 30 days): PCT and DCT showing apoptotic epithelial cells.

Fig 24

DAB 400X.

Fig 25. Spleen (group 2, 30 days): Apoptotic lymphocytes in white pulp area of spleen.

Fig 25

DAB 400X.

Table 8. Mean score (mean±SEM) of TUNEL positive (apoptotic) cells in different tissues in T-2 toxin induced apoptosis in toxicated and control groups on 15th and 30th days.
Organs/tissues (Days) Groups F value
10ppm (Group I) 20ppm (Group II) Control (III)
Liver 15 10.58±3.3aB 5.33±1.6aB 1.64±0.52b FG = 36.78**
FD = 13.78**
30 27.7±3.7aA 21.7±2.5aA 1.2±0.42b FDG = 3.68**
Intestine 15 4.7±1.17bB 16.6±2.6aB 1.8±0.32b FG = 73.69**
FD = 50.56**
30 20.7±2.2bA 40.7±4.2aA 1.2±0.30c FDG = 14.18**
MLN 15 4.8±0.9abB 6.1±1.1aB 1.8±0.6b FG = 39.64**
FD = 41.13**
FDG = 17.3**
30 10.5±2.1bA 22.2±1.9aA 2.1±0.9c
Kidneys 15 3.7±1.2bB 9.2±1.3aB 0.9±0.3b FG = 33.8**
FD = 29.2**
30 14.7±1.4bA 21.7±3.6bA 1.22±0.43c FDG = 7.38**
Spleen 15 4.6±0.19abB 7.1±1.2aB 3.1±0.7b FG = 14.3**
FD = 13.08**
30 12.5±1.3aA 9.3±1.4aA 2.9±0.9b FDG = 6.39**

The data were analyzed using one way-ANOVA, two way-ANOVA and independent (t) test, wherever applicable. Superscripts A, B shows differences in columns and a, b, c in rows. Mean bearing at least one common superscript didn’t show any difference. FD = effect within days (D), FG = effect within groups (G), FDG = interaction within days and groups *<0.05, **<0.01.

Differential expression of Heat shock proteins, pro-apoptotic proteins and pro-inflammatory cytokines

Differential expression of mRNA of HSP-72, 90 and 27 genes were studied in liver, intestine, MLN, kidneys, spleen and brain in response to T-2 toxin in all the three groups. Overall, the mRNA expression of all three HSPs in the organs tested was significantly upregulated in group II when compared to group I, suggesting that the higher dose has led to increased expression of these genes as a result of stress exerted by the toxin (Table 9). Specifically, the expression of HSPs in the liver, intestine and MLN was higher in group II than in group I (Fig 1a). On the contrary, in the kidney expression of HSP-90 was significantly (p = 0.51) upregulated in group II compared to the group I, whereas HSP-72 and HSP-27 did not differ significantly (p = 0.51 and -27 p = 0.27, respectively) between groups. Meanwhile, expression of HSP-72 and HSP-27 mRNA in the spleen was significantly high (p < 0.05) in group II than in group I. The expression of HSP-72 mRNA increased in group II than in group I on the 30th day. The expression of HSPs mRNA in brain did not differ between groups but showed up regulation than the control group.

Table 9. Effect of T-2 toxin on expression of Heat shock protein (HSP) genes in different tissues in 10ppm and 20ppm groups on 30th day.

Tissues Genes Groups Fold change (2-ΔΔct) ±SEM P value
Liver HSP-72 10ppm 11.93±0.34* 0.05
20ppm 21.50±2.22*
HSP-90 10ppm 4.63±0.79# 0.05
20ppm 23.85±4.24#
HSP-27 10ppm 7.93±0.85$ 0.05
20ppm 21.01±0.95$
Intestine HSP-72 10ppm 17.19±0.19* 0.05
20ppm 38.66±3.94*
HSP-90 10ppm 14.44±1.69# 0.05
20ppm 23.25±2.53#
HSP-27 10ppm 5.24±0.55$ 0.05
20ppm 8.95±0.67$
MLN HSP-72 10ppm 4.85±0.53* 0.05
20ppm 12.13±1.53*
HSP-90 10ppm 1.76±0.25# 0.05
20ppm 4.98±1.03#
HSP-27 10ppm 3.91±0.21 0.82
20ppm 3.87±0.9
kidneys HSP-72 10ppm 4.13±1.84* 0.05
20ppm 11.33±2.2*
HSP-90 10ppm 4.00±0.64 0.51
20ppm 3.74±0.37
HSP-27 10ppm 4.29±0.98 0.27
20ppm 5.51±0.59
Spleen HSP-72 10ppm 5.58±0.18* 0.05
20ppm 17.71±2.64*
HSP-90 10ppm 1.35±0.36 0.12
20ppm 1.82±0.59
HSP-27 10ppm 5.11±1.51$ 0.05
20ppm 3.38±0.69$
Brain HSP-72 10ppm 1.7±0.56 0.13
20ppm 4.08±0.79
HSP-90 10ppm 2.76±1.84 0.13
20ppm 5.68±1.07
HSP-27 10ppm 1.44±0.38 0.08
20ppm 2.62±0.24

The relative fold change (2-ΔΔct) expressions of 10 ppm and 20 ppm groups were compared relative to control on 30th day using Mann–Whitney U-test as implemented in version 16.0 of the SPSS software. The level of significance was set at P < 0.05.

Apoptotic genes

Caspase-3 and Bax are pro-apoptotic proteins whereas Bcl-2 is an anti-apoptotic protein. Expression of these genes will clearly suggest the activation of apoptosis within the tissues due to the T-2 toxin induced toxicity. In our study, hepatic mRNA expression of Caspase-3, Bax was significantly (p = 0.04 and p = 0.05, respectively) higher in group I than in group II on 30th day, whereas that of Bcl-2 did not differ significantly (p = 0.17) between groups. However, in the intestine with caspase-3 and bax gene expression were significantly higher in group II than in group I (p = 0.001 and p = 0.05, respectively) and the expression of Bcl-2 was upregulated in group I than in group II (p = 0.05). On the contrary, the expression of caspase-3 was significantly higher in group II (p = 0.03) and the expression of Bax and Bcl-2 were significantly higher in group I than in group II within the MLNs (p = 0.57 and p = 0.04, respectively). Meanwhile, within the kidney, caspase-3 was significantly higher in group II (p = 0.04), whereas Bax was higher in group I (p = 0.03). Within the spleen, the expression of Bax and Bcl-2 was significantly higher in group I (p = 0.05) with no significant change in caspase-3 expression, whereas the expression of caspase-3 was significantly higher (p = 0.05) in group I within the brain. Collectively, it was observed that, T-2 toxin at most instances induced the expression of caspase-3 as well as Bax, with little or no significant changes in Bcl-2, indicating the induction of apoptosis within all the organs studied. (Table 10).

Table 10. Effect of T-2 toxin on expression of apoptotic genes in different tissues in 10 ppm and 20 ppm groups on 30th day.
Tissues Genes Groups Fold change (2-ΔΔct) ±SEM P value
Liver Caspase 3 10ppm 24.31±1.14* 0.04
20ppm 12.15±0.57*
Bax 10ppm 3.85±0.91# 0.05
20ppm 9.34±1.52#
Bcl2 10ppm 0.47±0.11 0.17
20ppm 1.18±0.40
Intestine Caspase 3 10ppm 33.52±0.54** 0.001
20ppm 67.04±1.08**
Bax 10ppm 12.42±0.45# 0.05
20ppm 35.83±4.33#
Bcl2 10ppm 2.73±0.91$ 0.05
20ppm 1.89±0.16$
MLN Caspase 3 10ppm 20.87±2.3* 0.05
20ppm 41.74±4.6*
Bax 10ppm 43.06±5.52# 0.05
20ppm 13.44±2.26#
Bcl2 10ppm 3.00±0.34$ 0.05
20ppm 0.67±0.16$
kidneys Caspase 3 10ppm 10.02±0.49* 0.04
20ppm 32.78±5.44*
Bax 10ppm 8.82±1.65# 0.03
20ppm 4.11±0.83#
Bcl2 10ppm 3.13±0.24 0.57
20ppm 1.01±0.26
Spleen Caspase 3 10ppm 24.97±9.2 0.08
20ppm 15.24±1.15
Bax 10ppm 21.96±3.56# 0.05
20ppm 13.73±0.88#
Bcl2 10ppm 11.44±3.1$ 0.05
20ppm 2.7±0.57$
Brain Caspase 3 10ppm 4.27±0.60* 0.05
20ppm 1.96±0.20*
Bax 10ppm 1.40±0.43 0.5
20ppm 1.97±0.22
Bcl2 10ppm 1.6±0.67 0.67
20ppm 0.31±0.07

The relative fold change (2-ΔΔct) expressions of 10 ppm and 20 ppm groups were compared relative to control on 30th day using Mann–Whitney U-test as implemented in version 16.0 of the SPSS software. The level of significance was set at P < 0.05.

Pro-inflammatory cytokines (IL-1α, IL-6 and TNF-α)

Various locally produced pro-inflammatory stimuli such as IL-1, IL-6 and TNF-α can invade into the circulation and induce a systemic response against the oxidative stress induced by the exposure to the toxin. Thus, in our study we assessed the levels of these mediators in various organs. It was observed that the hepatic expression of IL-1α, IL-6 (p = 0.04; p = 0.05, respectively) were significantly upregulated in group II, whereas the expression of TNF-α (p = 0.05) was upregulated in group I as against the that of the intestine where IL-1α expression was upregulated in group I but the expression of IL-6 and TNF-α were upregulated in group II. Similarly, only TNF- α (p = 0.04) significantly increased in group I within MLNs and IL-6 and TNF-α (p = 0.004 and p = 0.05) both varied in the kidneys. However, the expression of only IL-1α significantly (p = 0.05) increased in the group II animals within the spleen and brain whereas the expression of IL-6 and TNF-α did not exhibit much variation in the spleen and brain tissues. (Table 11).

Table 11. Effect of T-2 toxin on expression of pro-inflammatory cytokine genes in different tissues in 10 ppm and 20 ppm groups on 30th day.
Tissues Genes Groups Fold change (2-ΔΔct) ±SEM P value
Liver IL-1α 10ppm 13.85±2.40* 0.04
20ppm 36.37±4.47*
IL-6 10ppm 3.62±0.18# 0.05
20ppm 9.54±0.93#
TNF-α 10ppm 23.85±1.87$ 0.05
20ppm 13.29±1.63$
Intestine IL-1α 10ppm 60.15±4.28* 0.05
20ppm 84.25±4.15*
IL-6 10ppm 11.11±1.01# 0.04
20ppm 26.08±4.03#
TNF-α 10ppm 42.12±5.78$ 0.05
20ppm 56.13±1.18$
MLN IL-1α 10ppm 11.72±1.28 0.16
20ppm 7.85±1.10
IL-6 10ppm 1.82±0.58 0.58
20ppm 4.22±0.13
TNF-α 10ppm 13.72±2.19$ 0.04
20ppm 6.36±0.46$
kidneys IL-1α 10ppm 2.14±0.17 0.12
20ppm 4.28±0.48
IL-6 10ppm 2.68±0.89# 0.04
20ppm 10.95±1.45#
TNF-α 10ppm 19.97±1.13$ 0.05
20ppm 8.69±0.88$
Spleen IL-1α 10ppm 17.72±1.47* 0.05
20ppm 25.4±4.76*
IL-6 10ppm 10.19±0.79## 0.001
20ppm 52.23±7.59##
TNF-α 10ppm 49.92±4.30$ 0.05
20ppm 12.59±1.22$
Brain IL-1α 10ppm 1.78±0.50* 0.05
20ppm 4.73±0.31*
IL-6 10ppm 2.42±0.46 0.32
20ppm 3.61±0.28
TNF-α 10ppm 3.83±1.04 0.17
20ppm 2.17±0.49

The relative fold change (2-ΔΔct) expressions of 10 ppm and 20 ppm groups were compared relative to control on 30th day using Mann–Whitney U-test as implemented in version 16.0 of the SPSS software. The level of significance was set at P < 0.05.

Discussion

In the present study, the experimental animals showed clinical symptoms such as diarrhea, feed refusal, lethargy and weakness after 15 days of toxin feeding at 10 and 20 ppm toxicity levels. The clinical signs exhibited by the animals in the present study were similar to those reported earlier by various workers in calves [38,39], sheep [18] and pigs[20]. Also, [18] reported that the lambs exposed to the T-2 toxin at a concentration of 0.6 mg/kg body weight for about 21 days exhibited periodic bouts of diarrhea and infection with Eimeria species, which are the clear symptoms of toxicosis. In addition, characteristics such as lethargy and feed refusal observed during the toxicosis might be due to the impairment in the central nervous system [40]. In some of the other studies, features of low feed consumption to complete feed refusal, reduced feed conversions for nutrient absorption, bloody diarrhea, reduction in milk production and absence of oestrus cycles were observed in the cattle with T-2 toxicosis [16,38]. In addition, findings from the studies of [19] suggest that T-2 toxicosis in sheep (aged 1.5–3 yrs) showed similar clinical symptoms as stated above. The complete feed refusal resulted in reduced body weight and in turn caused damage to the organs such as kidney, liver, GI and lymphoid tissues [41]. Studies have also suggested that T-2 toxicosis-induced diarrhea reduces the absorptive lining on the intestine and a corresponding reduction in the protein synthesis [10,42]. All these changes might have led to a significant reduction in the body weight of the experimental goats over a period of one month.

In our study, the dose- and duration-dependent reduction in the hemoglobin concentration (greater at a high concentration) was observed, which is probably due to its role on hematopoiesis and inhibition of protein synthesis and is well studied in several animal models such as rats, mice, guinea pigs, rabbits and cats [43,44]. The inhibition of hemoglobin synthesis can be due to the reduced uptake of 59Fe by the erythrocytes which in turn lead to a reduced Hb production [45,46]. In agreement with several other studies, severe leucopenia was also observed in our study in the toxin treated groups around the 30th day [41,47], along with increased myeloid to erythroid ratios in lambs at a toxin concentration of 0.6 mg/kg body weight and 0.3 mg/kg body weight per day fed in a protein low diet for 21 days [18]. Along with its effects on the hemoglobin content, the total platelet count was also reduced in our study on the 25th day of toxin exposure, which might be a resultant of the direct effect on the platelet progenitor differentiation and cytotoxicity [48]. Decreased platelet count was also reported in rabbits fed 0.5mg/kg T-2 toxin contaminated feed [47].

Group II on the 30th day exhibited significantly higher hepatic SOD and catalase enzymes, suggesting the release of ROS, along with an increase in the hepatic LPO activity in group I in the 15th day as well. [49]Reported that lipid peroxidation is not involved in T-2 toxin cytotoxicity. In contrast, [50] reported that T-2 toxin and deoxynivalenol (DON) stimulated lipid peroxidation in the liver of rats. These results suggest a direct effect of the toxin on the hepatic tissues at relatively lower doses administered for longer duration. It is a general understanding that oxidative stress is a resultant of either the generation of greater amount of ROS or reduced production of antioxidants within the cells [51,52]. Macromolecules critical to life namely the nucleic acids, lipids and proteins are the major targets of ROS, which further lead to tissue injury [53]. Oxidative damage around the 30th day post toxin exposure also led to severe histological alterations in the intestine including tissue necrosis of the epithelial lining and the lymphocytes in the lamina propria.

Apart from the generation of ROS, lipid peroxidation is also targeted by the toxin. However, reports on the T-2 toxin induced lipid peroxidation in animals are contradicting. [49] reported that lipid peroxidation is not involved in T-2 toxin cytotoxicity, whereas [50] reported that T-2 toxin and deoxynivalenol (DON) stimulated lipid peroxidation in the liver of rats. Some of the other studies report an increase in the lipid peroxide levels in the organs such as kidney, liver, thymus, bone marrow and spleen upon a single oral dose treatment of T-2 toxin @ 2 or 3.6 mg/kg body weight [48,53]. Similar to our findings, [33] reported an increase in the melonaldehyde, SOD and catalase enzymes in the liver and kidney tissue homogenates of the experimental rabbits after oral feeding of AFB1 @ 0.5ppm, ochratoxin @ 1ppm and in combination in rabbits on 30th and 60th day. Lipid peroxidation caused by T-2 toxin in liver and kidneys has been identified as an important underlying mechanism of T-2 toxin-induced cell injury, DNA damage and apoptosis [54]. On the contrary, the studies carried out by [55] demonstrated a marked reduction of SOD and catalase activity along with a concomitant increase in the LPO levels in the liver and kidney tissues after oral treatment of T-2 toxin @ 0.5ppm, 0.75ppm and 1ppm in rats.

Considering the fact that any foreign particle from the feeds should enter the body through the GI system, it was evaluated in this study. The lesions were observed on 15 and 30th day showing mild crypt epithelial hyperplasia, infiltration of lymphocytes and vascular engorgement in the mucosa which progressed to severe necrosis of crypt epithelia, lymphocytes in lamina propria, infiltration of epitheliod cells, macrophages and plasma cells in group II on 30th day. Similar lesions in gastrointestinal system have been described in various livestock species by several workers in trichothecenes toxicity [1115,38]. Such lesions also caused damage to the actively dividing cells lining the intestinal mucosa and leukocytes, suggesting the effects of the toxin on the intestinal cells [8]. Yet another study examined the T-2 toxicosis in piglets which showed congestion, hemorrhages and necrosis of the mucosal cells of GI and a direct effect on the lymphocytes and lymph nodes of the immune system. In a similar study on the pigs, [56] showed an increased endothelial lymphocytes and plasma cells of the epithelium along with a reduced number of goblets and underdeveloped glycocalyx in the epithelium of the intestine.

In the present study, the graded mean score of necrotic cells in crypt epithelium was significantly higher in group II but villous epithelium and LP did not show severe necrosis with low mean score of necrotic cells, which suggested that the cryptic epithelial cells were the primary targets for T-2 toxin exposure in intestine as this region consisted actively dividing cells [20]. Examination of the Peyer’s patched showed severely diffused lymphocytes and depletion of the lymphoid in the higher dosage group, which is in agreement with the histological findings from the study on piglets treated with T-2 toxin @ 1.5mg, 2mg and 2.5mg/kg of BW [8].

In addition, the epithelium of the intestine also revealed severe apoptotic modifications with a marked increase in the TUNEL positive cells in group II on the 30th day, which are also in agreement with the studies of Quiroga et al. [20] that described similar apoptotic changes in the intestinal crypt cells. It can thus be inferred from grading the apoptotic changes in the Peyer’s patches, intestinal crypts and lymphocytes that the intestinal lesions are in goats have similar pathogenesis as that in pigs [20].

Significant pathomorphological changes were also observed in the lymphoid organs (spleen, MLN and Peyer’s patches) in our present study. Our study demonstrated remarkable enlargement of the MLN post toxin treatment along with lymphoid necrosis and depletion in a dose-dependent manner. Similar findings were shown by [18] during T-2 toxicosis in sheep. They study demonstrated depletion of lymphocytes in the medullary and paracortical areas and germinal centers, presence of numerous pyknotic cells in the MLN and hypocellularity in the germinal centers of spleen and were similar to T-2 toxicosis in sheep [18], piglets [20] and AFB1and ochratoxin toxicity in rabbits [33]. In support to these findings, [43] demonstrated higher concentrations of the toxin in the lymphoid organs as early as 3 h after the intra-aortal administration in the experimental pigs. Such a fast penetration could be attributed to its lipophilic nature facilitating it to surpass the blood-brain barrier [9].

In addition to the lymphoid organs, kidneys have shown marked pathomorphological changes including degeneration of the epithelial lining of proximal and distal convoluted tubules, interstitial engorgement, renal tubular necrosis and accumulation of the pink stained material in the lumen. The dose- and duration-dependent modifications in the kidney tissues indicate the effect of toxin on these tissues. The harmful effects of the toxin is either via the generation of oxidative stress, as observed by the increased stress enzymes, or because of the renal damage rendered during the biotransformation of the toxin and its excretion as observed in the studies conducted by Konigs et al [57] and Wu et al [58].

Besides these organs, T-2 toxicosis has also affected the brain tissues demonstrated by a varying degree of characteristic lesions including engorgement of the vascular tissues, Purkinje and cortical cell neuronal degenerations, focal glial reaction and satellitosis in both the toxin treated groups on 30th day. Along with these characteristics, enhanced lipid peroxidation and greater levels of oxidative stress enzymes in the brain tissues. However, TUNEL assay could not detect apoptosis in the brain cells. Effects of T-2 toxicosis on the neuronal cells in the brain have not been well studied. The neurological effects of the T-2 toxins are thought to be a result of either the metabolic changes in the biogenic mono amines [59] or changes in the permeability of amino acids across the blood-brain barriers [60].

Further, at the cellular level the modifications varied with respect to the organs, namely, liver, intestine, kidneys and brain. The nuclear membrane remained indistinct along with loss of cristae and inner matrix leading to valuolation of the mitochondria, hyperplasia and dilation of the rough endoplasmic reticulum and condensation of the heterochromatin. Brain showed myelin figures due to neuronal degeneration in both the toxicated groups on 30th day. Overall, the results of the study showed that mitochondria was the most affected organelle rendering the pleomorphic (variable sizes and shapes–dumb bell, curved, rounded) mitochondria into opaque structure in the hepatocytes, enterocytes and epithelial cells of kidney tubules. Aflatoxin B1 and ochratoxin treatment in rabbits also revealed similar structural changes reported by [33]. In addition, treatment of ochratoxin (OTA) and citrinin (CTN) to the laboratory rats [61] revealed severe ultrastructural changes in the epithelial cells of PCT characterized by extensive loss of the brush border, cytoplasmic vacuolations and degeneration of nuclei with indistinct nuclear membranes and loss of nucleoli and pleomorphic mitochondria in rats treated with OTA @ 0.75 ppm and CTN @ 15 ppm and in combination. The present study is in agreement with these studies and several others suggesting that toxins indeed has the ability to cause cytotoxic effects in rats, rabbits and poultry [33,62,63].

The mechanism of apoptosis induction is via mitochondrial or non-mitochondrial mechanisms. Although not clear, it is expected to be via triggering the activation of stress-activated kinases c-Jun N-terminal kinase 1 (JNK1) and/or p38 MAPK (Mitogen activated protein kinases) [23,64]. In our study, extensive apoptosis was observed in the higher dose group in all the organs tested. Liver exhibited apoptotic cells in lower dose group also, whereas in the intestinal crypt epithelial cells apoptosis was observed at the higher dose group only. Similarly, the lymphoid and the kidney cells also showed significant apoptosis in a dose-dependent manner. T-2 induced apoptosis has been characterized by some of the previous studies suggesting its effects on the thymic and splenic lymphocytes, bone marrow and gastric mucosa, gastric glandular epithelium and intestinal crypt cell epithelium in mice [23,29,65]particularly in the skin [25]kidney and brain [66].

Crypt epithelial cells of the duodenum and lymphoid tissues have shown extensive apoptosis in previous studies as a result of the toxin treatment to the laboratory mice [65,67,68]. Large intestinal crypts showed relatively lesser apoptosis in comparison to the small intestine probably because the small intestine encounters the toxin and its metabolites more frequently during the mucosal absorption and biliary excretion [10]. With respect to the lymphoid tissues, in a previous study on the laboratory mice it was observed that the degree of apoptosis varied in the different organs but were extensively affect in all the organs studied [68]. Similarly, in the present study the toxin affected all the lymphoid organs at varying degree in a dose dependent manner. Hepatocytes were also significantly affected and graded in our study. Hepatic lesions were graded using the features such as hepatocyte degeneration and necrosis, sinusoidal congestion, centrilobular degeneration and necrosis, hyperplasia, thickening and peri ductular tissue proliferation and fibrosis of the bile duct. A consistent, time- and dose-dependent necrosis was observed in the in the hepatocytes probably due to the exposure to ROS generated by the toxin administration [69]. Similar studies carried out by [70]described hepatic lesions of centro-lobular dystrophy and necrosis of cells of the mononuclear phagocyte system in rabbits treated with oral dose of 1, 2, 4, 6, 8, 10 or 15 mg/kg body mass of T-2 for 24 to 48 hours.

In addition to the characteristic ultra-structural modifications, toxin treatment also induces activation of heat shock proteins, which are generated by the cells in response to stress, injury and hyperthermia. They are a class of highly conserved stress response proteins expressed ubiquitously in the cells at basal levels under normal conditions. They play the role of molecular chaperons and assist proteins to fold, prevent aggregation of proteins and channelize the unfolded proteins for degradation [71]. They also have a prime role in protecting the cells against oxidative damage by enhancing the protein activity and endogenous antioxidant stability [72].

In the present study, expression of HSP-72,90 and 27 were significantly upregulated in all the organs tested at the toxin concentration of 10 ppm and 20 ppm on 30th day. However, the mRNA expression of hepatic, intestinal and MLN were the highest in group II on the 30th day, which was in line with the study on the mRNA expression in rats using microarray analysis [66]. Kidney tissue homogenate also exhibited significant up regulation of HSP-72 whereas the other HSPs tested (HSP-90 and HSP-27) were not significantly varying. On the contrary, the expression of HSP-72 and HSP-27 were increased in the spleen tissues of the higher dose group whereas that in the brain did not differ remarkably between the two groups but was higher than the control. Previous studies have confirmed the elevated ROS- induced oxidative stress to the cells by the treatment of Zearalenone, citrinin and T-2 toxins [2325,73]. These studies reveal a strong relationship of oxidative stress and HSPs thus indicating its use as a biomarker to assess oxidative damage to the cells.

Likewise, the expression of pro-apoptotic genes such as Caspase 3 and Bax were also evaluated in the liver, kidney, MLN, intestine, spleen and brain tissues. The expression was significantly higher than the control group in all the organs tested. However, the anti-apoptotic gene (Bcl-2) expression was lower than the control in both the toxin treated groups. Overall, the extensive apoptotic changes induced by T-2 toxin might be due to the significant up regulation of pro-apoptotic genes such as Caspase 3 and Bax as well as reduced expression of anti-apoptotic gene Bcl-2 in different organs. Previous studies have substantiated the present findings suggesting that the toxin treatment regulated the expression of apoptosis-related genes like caspase-2 and insulin-like growth factor binding protein-3, trigger apoptosis by releasing cytochrome c, and activate caspase-9, -7, and -3 [66,74,75]. Caspase-3 induces apoptosis by activating a cascade of proteins ultimately resulting in cell death [76].Likewise, the Bcl-2 to Bax ratio is a deciding factor of the fate of cell. Therefore, our study showing significant increase in the Caspase-3 along with a concomitant decrease in the Bcl-2 to Bax ratio suggest the intricate linkage of these two signals in the induction of apoptosis.

Exposure to the trichothecene class of toxins has both immune-stimulatory and suppressive potential based on the dosage, duration and frequency. They target the immune cells such as lymphocytes, macrophages and monocytes leading to the expression of cytokines, chemokines and pro-inflammatory genes [77]. Further, at a greater concentration range they lead to apoptosis of the leukocytes and a corresponding immune suppression. These toxins bind to the ribososmes and activate mitogen-activated protein kinases (MAPKs) along with the regulation of immune and inflammatory genes. Stimulation of mononuclear phagocytes by low doses or concentrations of trichothecenes elicit expression of inflammation-related genes in vivo and in vitro including cyclooxygenase-2 (COX-2), pro-inflammatory cytokines and numerous chemokines [78].

Likewise, the pro-inflammatory cytokines, namely, IL-1α, IL-6 and TNF-α were significantly up in both the groups when compared to the control group on 30th day. It was observed that the expression was more in higher dose exposed animals, which was in agreement with the earlier studies [78]. Similar studies by [79] reported up regulation of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α mRNA in the peritoneal macrophages of mice after exposure to TLR agonists (LPS and DON) and after 16h. Studies have affirmed the up regulation of pro-inflammatory cytokines via the MAPK pathway [80]. Our results uphold these findings because of the significant up regulation of IL-1α and IL-6 mRNA in spleen whereas only IL-1α expression was up regulated in the brain in the group treated with the higher concentration of the toxin. On the contrary, all the organs exhibited a significant increase in the TNF-α gene expression in the lower concentration treated group. TNF-α in responsible for the induction of apoptosis via Fas mediated cascade for the initiation of apoptosis and thus increase in its concentration indicates the activation of this pathway as a result of the toxin treatment.

Infiltration of the lymphocytes and macrophages in the intestinal lamina propria observed in the present study has a strong link to the generation of inflammatory cytokines. This indicates that these cytokines are indeed responsible for the inflammatory response by these cells. Such vascular changes induced chronic anorexia and reduced weight gain, immuno-suppression and tissue injury [81]. Even in the present study, these features were observed in the laboratory mice. Similar findings were elaborated in a recent study on piglets showing DON toxicity caused Salmonella infection, which in turn led to inflammatory responses [82]. The intestinal epithelial cells were made vulnerable for the pathogen attack because of immuno-suppression. Therefore, the lesions observed in our study can be substantiated as a resultant of the inflammation caused by the toxin.

Therefore, the present study establishes a positive association among oxidative stress and the gene markers of stress such as HSPs, the apoptosis inducer genes like Caspase-3 and cytokines by the administration of T-2 toxin. Hence, both oxidative, apoptotic and inflammatory mechanisms are responsible for the pathogenesis of this toxicosis in goats.

Conclusion

The present study demonstrates a complex relation between HSPs, pro-apoptotic proteins and pro-inflammatory cytokines because of T-2 toxin treatment. This is the first study establishing the effects of T-2 toxin-induced toxicity and pathological changes in juvenile goats. The study shows that T-2 toxin exerts toxic effects through a cumulative effect of oxidative, apoptotic and inflammatory pathways. This study provides a basis for understanding the toxicity, which can be further extrapolated for other animals as well.

Acknowledgments

The authors are thankful to the Director, Indian Veterinary Research Institute, Izatnagar, India, Director, Central Institute for Research on Goats, Mathura and Joint Director, HSADL, Bhopal, India for providing necessary facilities to carry out the work.

Data Availability

All relevant data are within the paper.

Funding Statement

The entire work was not funded by any agency.

References

  • 1.FAO/WHO Expert Committee on Food Additives, Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint. World Health Organ Tech Rep Ser.2002; 906: 1–62. [PubMed] [Google Scholar]
  • 2.Fink GJ, Malekinejad H. Biochemical mechanisms and clinical effects associated with exposure to the mycoestrogenzearalenone. In: Morgavi DP, Riley RT. (Eds.), Fusarium and their toxins: Mycology, occurrence, toxicity, control and economic impact. Anim Feed Sci Technol. 2007. [Google Scholar]
  • 3.Morgavi D, Riley RT. An historical overview of field disease outbreaks known or suspected to be caused by consumption of feeds contaminated with Fusarium toxins. In: Morgavi DP, Riley RT. (Eds.), Fusarium and their toxins: Mycology, occurrence, toxicity, control and economic impact. Anim. Feed Sci. Technol. 2007. [Google Scholar]
  • 4.Pestka JJ. Deoxynivalenol: toxicity, mechanisms and health risks. In: Morgavi DP, Riley RT. (Eds), Fusarium and their toxins: Mycology, occurrence, toxicity, control and economic impact. Anim. Feed Sci. Technol. 2007. [Google Scholar]
  • 5.Voss KA, Haschek WM. Fumonisins: toxicokinetics, mechanism of action and toxicity. In: Morgavi DP., Riley RT. (Eds.), Fusarium and their toxins: Mycology, occurrence, toxicity, control and economic impact. Anim. Feed Sci. Technol. 2007. [Google Scholar]
  • 6.Frisvad JC, Thrane U, Samson RA, Pitt JI. Important mycotoxins and thefungi which produce them In: Advances in Food Mycology, Hocking AD, Pit JI, Samson RA, Thrane U. (Eds.), Springer, New York, USA: 2006;3–31 [Google Scholar]
  • 7.Joseph R, Derbyshire M, Stroka J, Emons H, Anklam E. Trichothecenes:reference materials and method validation. ToxicolLett. 2004; 153: 123–132. [DOI] [PubMed] [Google Scholar]
  • 8.Jaradat ZW. T-2 mycotoxin in the diet and its effects on tissues In: Reviews in Foodand Nutrition Toxicity, Watson RR, Preedy VR. (Eds). Volume 4 CRCPress; 2005; 173–212. [Google Scholar]
  • 9.SCF (Scientific Committee on Food). Opinion of the Scientific Committee on Food on Fusarium Toxins. Part 5: T-2 Toxin and HT-2 Toxin. 2001.
  • 10.Mann DD, Buening GM, Hook B, Osweiler GD. Effects of T-2 mycotoxin on bovine serum proteins. J Am Vet Med Assoc. 1983; 44: 1757–1759. [PubMed] [Google Scholar]
  • 11.Wannemacher RW, Brunner DL, Neufeld HA. Toxicity of trichothecenes and other related mycotoxins in laboratory animals In: Smith J.E. and Henderson R.S. (Eds.), "Mycotoxins and Animal Foods." CRC Press, Inc, Boca Raton FL: 1991. pp. 499–552. [Google Scholar]
  • 12.Hsu IC, Smalley CB, Strong FM, Ribelin WE. Identification of T-2 toxin in moldy corn associated with a lethal toxicosis in dairy cattle. Appl Microbiol.1972; 24: 684–690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mirocha CJ. Metabolism and residue of trichothecene toxins in animal and plant systems In: Steyn P.S. and Vleggier R., eds; Mycotoxins and phytotoxins, Elsevier, Amsterdem, 1976. p.409. [Google Scholar]
  • 14.Petrie L, Robb J, Stewart AF. The identification of T-2 toxin and its association with a haemorrhagic syndrome in cattle. Vet Rec. 1977; 101: 326–326. 10.1136/vr.101.16.326 [DOI] [PubMed] [Google Scholar]
  • 15.Helferich WG, Garrett WN, Hsieh DPH, Baldwin RL. Feedlot performance and tissue residues of cattle consuming diets containing aflatoxins. J Anim Sci. 1986; 62: 691–696. 10.2527/jas1986.623691x [DOI] [PubMed] [Google Scholar]
  • 16.Kegl T, Vanyi A. T-2 fusariotoxicosis in a cattle stock. Magyar AllatorvosokLapja.1991; 46: 467–471. [Google Scholar]
  • 17.Cheeke PR. Mycotoxins in cereal grains and supplements In: Cheeke P.R. (Ed.), Danville, IL: Interstate Publishers, Inc, 1998. 87–136. [Google Scholar]
  • 18.Friend SCE, Hancock DS, Schiefer HB and Babiuk LA. Experimental T-2 toxicosis in sheep. Can J Comp Med. 1983; 47: 291 [PMC free article] [PubMed] [Google Scholar]
  • 19.Ferreras MC, Benavides J, Garcia Pariente C, Delgado L, Fuertes M, Munoz M, et al. Acute and chronic disease associated with naturally occurring T-2 mycotoxicosis in sheep. J Comp Pathol. 2013; 148: 236–242. 10.1016/j.jcpa.2012.05.016 [DOI] [PubMed] [Google Scholar]
  • 20.Quiroga MA, Miguel AR, Carlos JP. T-2 mycotoxin intoxication in piglets: a systematic pathological approach and apoptotic immune-histochemical studies. Braz J Vet Pathol. 2009; 2(1): 16–22. [Google Scholar]
  • 21.Boonchuvit B, Hamilton PB,Burmeister HR. Interaction of T-2 toxin with Salmonella infections of chickens. Poult Sci. 1975; 541–693. [DOI] [PubMed] [Google Scholar]
  • 22.Shokri F., Heidari M., Gharagozloo S., Ghazi-Khansari M. In vitro inhibitoryeffects of antioxidant on cytotoxicity of T-2toxin. Toxicol. (2000); 146: 171–176. [DOI] [PubMed] [Google Scholar]
  • 23.Sehata S, Kiyosawa N, Atsumi F, Ito K, Yamoto T, Teranishi M, et al. Microarray analysis of T-2 toxin-induced liver, placenta and fetal liver lesions in pregnant rats. ExpToxicolPathol. 2005; 57: 15–28. [DOI] [PubMed] [Google Scholar]
  • 24.Bouaziz C, Abid-Esse S, Bouslimi A, El Golli E, Bacha H. Cytotoxicity and related effects of T-2 toxin on cultured Vero cells. Toxicon. 2006. 48: 343–352. 10.1016/j.toxicon.2006.06.004 [DOI] [PubMed] [Google Scholar]
  • 25.Albarenque Stella M., Shinozuka J., Iwamoto S., and Nakayama H. T-2 toxin-induced acute skin lesions in 3 Wistar-derived hypotrichotic WBNIILA-Htrats.Histol. Histopathol 1999; 14(2): 337–42. [DOI] [PubMed] [Google Scholar]
  • 26.Ahmadi K, Riazipour M. Effects of T-2 toxin on cytokine production by miceperitoneal macrophages and lymph node T-cells. Iran. J. Immunol.2008; 5(3):177–180. doi: IJIv5i3A6 [PubMed] [Google Scholar]
  • 27.Meissonnier GM, Laffitte J, Raymond I, Benoit E, Cossalter A M, Pinton P, et al. Subclinical doses of T-2 toxin impairacquired immune response and liver cytochrome P450 in pigs. Toxicol. 2008;247:46–54. [DOI] [PubMed] [Google Scholar]
  • 28.Junko S, Guanmin Li, Wijit K, Koji U, Hiroyuki N, Kunio D. T-2 toxin-induced apoptosis in lymphoid organs of mice. ExpToxicolPathol. 1997; 49(5): 387–392. [DOI] [PubMed] [Google Scholar]
  • 29.Shinozuka J, Li G, Kiatipattanasakul W, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in lymphoid organs of mice. ExpToxicolPathol. 1998; 49: 387–392. [DOI] [PubMed] [Google Scholar]
  • 30.Li Guanmin, Junko S, Koji U, Hiroyuki N, Kunio D. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. ExpToxicol Pathol.1997; 49: 447–450. [DOI] [PubMed] [Google Scholar]
  • 31.Wu J, Jing L, Yuan H, Peng SQ. T-2 toxin induces apoptosis in ovarian granulosa cells of rats through reactive oxygen species-mediated mitochondrial pathway. ToxicolLett. 2011; 202:168–177. [DOI] [PubMed] [Google Scholar]
  • 32.AOAC. Official Method of Analysis. 16th ed Washington, DC: Assoc. Off. Anal. Chem; 1995. [Google Scholar]
  • 33.Prabhu PC, Dwivedi P, Sharma AK. Toxicopathological studies on the effects of aflatoxin B(1), ochratoxin A and their interaction in New Zealand White rabbits. Exp Toxicol Pathol. 2013; 65: 277–286. 10.1016/j.etp.2011.09.003 [DOI] [PubMed] [Google Scholar]
  • 34.Shivasharanappa Nayakwadi. Pathomorphological and molecular studies of T-2 mycotoxicosis in goats. Ph.D thesis. IVRI, Izatnagar. 2013
  • 35.Luna LG. Manual of histological staining methods of the armed forces institute of pathology, 3rd Ed W.B. Saunders, Philadelphia: 1972. [Google Scholar]
  • 36.Watson ML. Staining of tissue sections for electron microscopy with heavy metals. J BiophysBiochemCytol. 1958; 4: 475–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963; 17: 208–12. 10.1083/jcb.17.1.208 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Weaver GA, Kurtz HJ, Mirocha CJ, Bates FY, Behrens JC, Robison TS, et al. The failure of T-2 mycotoxin to produce haemorrhagic symptoms in dairy cattle. Can Vet J. 1980; 21: 210–213. [PMC free article] [PubMed] [Google Scholar]
  • 39.Yiannikouris A, Jouany JP. Mycotoxins in feeds and their fate in animals: a review. Anim Res. 2002; 51: 81–99. [Google Scholar]
  • 40.Wang L, Fitzpatrick DW, Wilson JR. Effect of dietary T-2 toxin on biogenic monoamines in discrete areas of the rat brain. Food ChemToxicol. 1993; 31: 191–197. [DOI] [PubMed] [Google Scholar]
  • 41.Gentry PA, Ross ML, Chan PKC. Effect of T-2 toxin on bovine haematological and serum enzyme parameters. Vet HumToxicol. 1984; 26: 24–24. [PubMed] [Google Scholar]
  • 42.Pier AC, Richard JL, Cysewski SJ. The implication of mycotoxins in animal disease. J Am Vet Med Assoc. 1980; 176: 719–722. [PubMed] [Google Scholar]
  • 43.World Health Organization (WHO). Selected Mycotoxins: Ochratoxin, Trichothecenes, Ergot. Environmental Health Criteria. 1990. [Google Scholar]
  • 44.Doi K, Shinozuka J, Sehata S. T-2 toxin and apoptosis. J ToxicolPathol.2006; 19: 15–27. [Google Scholar]
  • 45.Schoental R, Gibbards S. Increased excretion of urinary porphyrins by white rats given intra-gastrically the chemical carcinogens diethylnitrosamine, monocrotaline, T-2 toxin and ethylmethanesulphonate. BiochemSoc Trans. 1979; 7: 127–129. [DOI] [PubMed] [Google Scholar]
  • 46.Faifer GC, Godoy HM. Acute effect of T-2 toxin on radioactive iron incorporation into circulating erythrocytes in mice. Toxicol.1991; 5: 169–174. [DOI] [PubMed] [Google Scholar]
  • 47.Gentry PA, Cooper ML. Effect of Fusarium T-2 toxin on haematological and biochemical parameters in the rabbit. Can J Comp Med. 1981; 45: 400–405. [PMC free article] [PubMed] [Google Scholar]
  • 48.EC (European commission). Opinion of the Scientific Committee on Food on Fusarium-toxins Part 5: T-2toxin and HT-2 toxin. 2001.
  • 49.Schuster A, Hunder G, Fichtl B, Forth W. Role of lipid peroxidation in the toxicity of T-2 toxin. Toxicon.1987; 25 (12): 1321–1328. 10.1016/0041-0101(87)90010-9 [DOI] [PubMed] [Google Scholar]
  • 50.Segal R, Milo Goldzweig I, Joffe AZ, Yagen B. The hemolytic activity of T2 toxin. ToxicolApplPharmacol. 1983; 70: 343–348. [DOI] [PubMed] [Google Scholar]
  • 51.Chaudhari M, Jayaraj R, Bhaskar ASB, Rao PVL. Oxidative stress inductionby T-2 toxin causes DNA damage and triggers apoptosis via caspase pathway inhuman cervical cancer cells. Toxicol. 2009a; 262: 153–161. [DOI] [PubMed] [Google Scholar]
  • 52.Chaudhari M, Jayaraj R, Santhosh SR. Rao PVL. Oxidative damage andgene expression profile of antioxidant enzymes after T-2 toxin exposure in mice. JBiochemMolToxicol. 2009b; 23: 212–221. [DOI] [PubMed] [Google Scholar]
  • 53.Rocha O, Ansari K, Doohan FM. Effects of trichothecenesmycotoxins on eukaryotic cells: a review. Food AdditContam. 2005; 22: 369–378. [DOI] [PubMed] [Google Scholar]
  • 54.Atroshi FE, Rizzo A, Biese I, Veijalainen P, Antila E, Westermarck T. T-2 toxin-induced DNA damage in mouse livers: The effect of pre-treatment with coenzyme Q and α-tocopherol. Mol Aspects Med. 1997; 18 (1): 255–258. [DOI] [PubMed] [Google Scholar]
  • 55.Sachin RS. Experimental reproductive toxicity and teratogenicity of t-2 toxin in Wistar rats with its effect on offsprings up to f-2 generation. Ph.D thesis. IVRI, Izatnagar. 2012.
  • 56.Obremski K, Zielonka L, Gajecka M, Jakimiuk E, Bakula T, Baranowski M, et al. Histological estimation of the small intestine wall after administration of feed containing deoxynivalenol, T-2 toxin and zearalenone in the pig. Pol J Vet Sci. 2008;11:339–345. [PubMed] [Google Scholar]
  • 57.Konigs M, Mulac D, Schwerdt G, Gekle M, Humpf HU. Metabolism and cytotoxic effects of T-2 toxin and its metabolites on human cells in primary culture. Toxicol. 2009; 258: 106–115. [DOI] [PubMed] [Google Scholar]
  • 58.Wu Q, Dohnal V, Huang L, Kuca K, Yuan Z. Metabolic pathways of trichothecenes. Drug Metab Rev. 2010; 42: 250–267. 10.1080/03602530903125807 [DOI] [PubMed] [Google Scholar]
  • 59.Boyd KE, Fitzpatrick DW, Wilson JR, Wilson LM. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens. Can J Vet Res. 1988; 52: 181–185. [PMC free article] [PubMed] [Google Scholar]
  • 60.Wang J., Fitzpatrick D.W. and Wilson J.R. Effect of T-2 toxin on blood-brain barrier permeability monoamine oxidase activity and protein synthesis in rats.Food Chem. Toxicol.1998;36: 955–961. 10.1016/s0278-6915(98)00079-9 [DOI] [PubMed] [Google Scholar]
  • 61.Manojkumar. Toxicopathology of simultaneous feeding of ochratoxin A and citrinin in rabbits. M.V.Sc, IVRI, Deemed University. 2007.
  • 62.Prasanna K. Molecular Pathology of ochratoxicosis in rats and detection of the toxin by enzyme-linked immunosorbent assay. Ph.D. thesis, submitted to Deemed University, IVRI, Izatnagar, U.P., India. 2003
  • 63.Dwivedi P, Burns RB, Maxwell MH. Ultrastructural study of the liver and kidney in ochratoxicosis A in young broiler chicks. Res Vet Sci. 1984; 36: 104–116. [PubMed] [Google Scholar]
  • 64.Yang GH, Jarvis BB, Chung YJ, Pestka JJ. Apoptosis induction by satratoxins and other trichothecenemycotoxins: Relationship to ERK, p38 MAPK, and SAPK/JNK activation. ToxicolApplPharmacol. 2000; 164: 149–160. [DOI] [PubMed] [Google Scholar]
  • 65.Shifrin VI, Anderson P. Trichothecenemycotoxins trigger aribotoxic stress response that activates c-Jun N-terminal kinase and p38mitogen-activated protein kinase and induces apoptosis. J Biol Chem.1999; 274: 13985–13992. 10.1074/jbc.274.20.13985 [DOI] [PubMed] [Google Scholar]
  • 66.Li G, Shinozuka J, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in Peyer’s patches of mice. J ToxicolPathol.1997; 10: 59–61. [Google Scholar]
  • 67.Sehata S, Kiyosawa N, Atsumi F, Ito K, Yamoto T, Teranishi M, et al. Morphological and microarray analysis of T-2 toxin-induced rat fetal brain lesion. Food ChemToxicol. 2004; 42: 1727–1736. [DOI] [PubMed] [Google Scholar]
  • 68.Li G, Shinozuka J, Uetsuka K, Nakayama H, Doi K. T-2 toxin-induced apoptosis in intestinal crypt epithelial cells of mice. ExpToxicolPathol. 1997; 49: 447–450. [DOI] [PubMed] [Google Scholar]
  • 69.Nagata T, Suzuki H, Ishigami N, Shinozuka J, Uetsuka K, Nakayama H, et al. Development of apoptosis and changes in lymphocyte subsets in thymus, mesenteric lymph nodes and Peyer's patches of mice orally inoculated with T-2 toxin. ExpToxicolPathol. 2001; 53(4): 309–315. [DOI] [PubMed] [Google Scholar]
  • 70.Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicol. 2000; 153(1–3): 83–104. [DOI] [PubMed] [Google Scholar]
  • 71.Glavits R, Vanyi A, Fekete S, Tamas J. Acute toxicologicalexperiment of T-2 toxin in rabbits. Acta VetHung. 1989; 37: 75–79. [PubMed] [Google Scholar]
  • 72.Hartl FU. Molecular chaperones in cellular protein folding. Nature. 1996;381:571–579. 10.1038/381571a0 [DOI] [PubMed] [Google Scholar]
  • 73.Polla BS, Kantengwa S, Francois D. Mitochondria are selective targets forthe protective effects of heat shock against oxidative injury. Proc. Natl. Acad. Sci.U.S.A. 1996; 93: 6458–6463. 10.1073/pnas.93.13.6458 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Hassen W, El Golli E, Baudrimont I, Mobio TA, Ladjimi M, Creppy EE, et al. Cytotoxicity and HSP-70 induction in Hep G2 cells in response to Zearalenone and cytoprotection by sub-lethal heat shock. Toxicology. 2005; 207: 293–301. 10.1016/j.tox.2004.10.001 [DOI] [PubMed] [Google Scholar]
  • 75.Nagase M, Alam MM, Tsushima A, Yoshizawa T, Sakato N. Apoptosis induction by T-2 toxin: activation of caspase9,caspase-3, and DFF-40/CAD through cytosolic release ofcytochrome c in HL-60 cells. Biosci. Biotechnol. Biochem.2001;65: 1741–1747. 10.1271/bbb.65.1741 [DOI] [PubMed] [Google Scholar]
  • 76.Nagase M, Shiota T, Tsushima A, Murshedul AM, Fukuoka S, Yoshizawa T, et al. Molecular mechanism ofsatratoxin-induced apoptosis in HL-60 cells: activation of caspase8and caspase-9 is involved in activation of caspase-3. Immunol.Lett.2002;84: 23–27. 10.1016/s0165-2478(02)00127-x [DOI] [PubMed] [Google Scholar]
  • 77.Wang GY, Zhang JW, Lu QH, Xu RZ, Dong QH. Berbamine induces apoptosis in human hepatoma cell line SMMC7721 by loss in mitochondrial transmembranepotentialand caspase activation.J.ZhejiangUniv.Sci. 2007; 8(4):248–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Pestka JJ, Zhou HR, Moon Y, Chung YJ. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox. ToxicolLett. 2004; 153(1): 61–73. [DOI] [PubMed] [Google Scholar]
  • 79.Wong SS, Zhou HR, Marin-Martinez ML, Brooks K, Pestka JJ. Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecenevomitoxin in the RAW 264.7 murine macrophage cell line. Food ChemToxicol. 1998; 36(5): 409–419. [DOI] [PubMed] [Google Scholar]
  • 80.Pestka JJ, Zhou H. Toll-like receptor priming sensitizes macrophages to pro inflammatory cytokine gene induction by deoxynivalenol and other toxicants. Toxicological Sciences. 2006;92(2): 445–455 10.1093/toxsci/kfl012 [DOI] [PubMed] [Google Scholar]
  • 81.Pestka JJ. Mechanisms of deoxynivalenol-induced gene expression and apoptosis.FoodAdditContam Part AChem Anal Control Expo Risk Assess. 2008;25(9): 1128–1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Vandenbroucke V, Croubels S, Martel A, Verbrugghe E, Goossens J, Van Deun K, et al. The mycotoxin deoxynivalenol potentiates intestinal inflammation by Salmonella typhimurium in porcine ileal loops. PLoS One. 2011;6: e23871 10.1371/journal.pone.0023871 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Natarajan Aravindan

6 Dec 2019

PONE-D-19-26666

Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats

PLOS ONE

Dear Dr Basalingappa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewers appreciated the work but raised some serious concerns. Please address every single critique raised by both the reviewers for further consideration.

We would appreciate receiving your revised manuscript by Jan 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Natarajan Aravindan

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2) Please amend the manuscript submission data (via Edit Submission) to include authors Anil Kumar Sharma, VivekKumar Gupta., K. Rajukumar, Vijay Kumar and Prithvi S Shirahatti.

3) Please include a copy of Tables 1 to 11 which you refer to in your text.

4) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this study entitled " Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats", Nayakwadi et al. have delineated the mechanisms by which T-2 toxin induced toxicosis in goats. The authors demonstrated that T-2 toxin elicited significant haematological, biochemical and histological alterations in several tissues including liver, intestine, kidney, spleen, brain etc. They reported altered expression of HSPs, pro-apoptotic and pro-inflammatory cytokines upon exposure to this toxin. Finally, they concluded that the T-2 toxicosis is mediated through oxidative, apoptotic and inflammatory mechanisms in goats. This study is very important as this toxin has been considered to elicit fatal reactions among animals and humans upon consumption. The findings from this study may open a new avenue in understanding the T-2 toxicosis in goats, which may be helpful in diagnosis and prevention of diseases in goats.

The study is well designed and the manuscript is fairly written, however, few queries need to be answered.

Major Comments:

1. Did the authors observe any pathological lesions in rumen or other compartments of stomach during 15th and 30th day of toxin treatment? Any additional data related to this may strengthen the current findings.

2. Under the Materials and Methods, in the lines 169-170, DAPI is mentioned as chromogen. However, the authors have used DAB as chromogen in TUNEL kit. This needs to be corrected. Also the sentences in the lines 183-186 should be removed as the authors have performed real-time RT-PCR and therefore sequencing is not required in mRNA expression studies.

3. Under the results, in line 215, the authors mentioned that "no mortality was observed during the experimental period". Did they observe any abnormal signs in the toxin treated groups during the study? Supportive evidences may be provided in this section.

4. What is the rationale for assessing IL-1apha than IL-1 beta gene expression, since IL-1beta is more potent than IL-1alpha in stimulating IL-6 release in several tissues?

5. The discussion is too descriptive and need to shortened with straightforward discussion.

6. The conclusion needs to be rewritten as it is not clear.

Minor Comments:

1. The authors should mention the name of the authors while referring to the methodology. e.g. Under Materials and Methods, in line 95, the authors mentioned "produced by fermentation of maize and wheat mixture as per the method described by [32]". Similarly, in line 139, the authors mentioned "MLN and brain tissue homogenates for all the animals on 15th and 30th day according to [33]". The authors name should be mentioned in those places.

2. In Figure legend 15: Correct the spelling of " sattellitosis".

3. Cross check the image magnification (both bright field and EM) in all the figures.

4. In the Table 1, under Control, with respect to Route of administration, it has been mentioned "Oral (Mixed with feed)". Did the control feed was mixed with any vehicle?

5. The Table 5 legend reads "T-2 Toxin induced histological alterations (score card) in different organs of young kids on 15th and 30th days fed with 10ppm and 20ppm dose". Remove the word "young kids" and change to "goats".

6. Under "Table 9: Effect of T-2 toxin on expression of heat shock protein (HSP) genes in different tissues in 10ppm and 20ppm groups on 30th day", the P value of some of the HSP mRNA expression levels are greater than P<0.05, which suggest no significant difference between the 10 and 20 ppm toxin treated goats and control. However, the "Expression pattern" suggests "up regulation". So check all the parameters.

7. The authors should strictly follow the references as per the journal format.

8. The manuscript should be checked for grammatical corrections and uniformity to match with the journal format.

Reviewer #2: This study throws light on the effect of T-2 mycotoxin contamination in juvenile goats and holds promise in goat husbandry considering their importance in economy and international trade. The authors have extensively studied the impact of T-2 mycotoxin in goats with respect to their growth and pathophysiology. Following are the queries that the authors need to address before it goes for publication.

1. The authors have stated that such studies have been carried out in other animals like sheep, pigs and poultry. In that case, what is the novelty of this study other than the organism used?

2. It has been mentioned that the toxin was mixed with the feed at specific concentrations. Is there any way the authors could assess the amount of toxin ingested by each animal?

3. The authors could give a possible explanation for the elevated levels of HSP molecules in the brain of control animals as opposed to those treated with the toxin.

4. The figure legends are obscure and very cryptic. It should be more descriptive for the readers to follow the results.

5. There are a few typographical errors that need to be corrected.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Mar 26;15(3):e0229463. doi: 10.1371/journal.pone.0229463.r003

Author response to Decision Letter 0


27 Jan 2020

Response to the Reviewer’s comments

Dear Professor

All the authors sincerely thank the editor/s and the reviewers for considering our manuscript significant and providing their valuable time and suggestion to improve the quality of the manuscript. Considering the thoughtful inputs the entire manuscript has been reformed after carrying out necessary incorporations. All the changes incorporated by the authors have been carried using “Track changes” option as suggested. The changes have been followed and remodelled in the respective sections as per the instructions given by the reviewers and as per the guidelines of the journal.

Accordingly, the issues that are raised by reviewers are being addressed in the revised manuscript and here we answer it point-by-point:

Additional requirements Points

1. Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming.

Answer: As suggested the manuscript has been re-checked to meet the PLOS ONE’s style requirements referring to the PLOS ONE journal template.

2) Please amend the manuscript submission data (via Edit Submission) to include authors Anil Kumar Sharma, Vivek Kumar Gupta., K. Rajukumar, Vijay Kumar and Prithvi S Shirahatti.

Answer: As suggested, all the Authors (Anil Kumar Sharma, Vivek Kumar Gupta., K. Rajukumar, Vijay Kumar and Prithvi S Shirahatti) have been included via edit submission.

Also we wish to bring to your kind notice that an author Rashmi L has been included in the manuscript and in edit submission which was not included during the initial stage by mistake and her contribution has also been incorporated in the manuscript.

3) Please include a copy of Tables 1 to 11 which you refer to in your text.

Answer: As suggested, a copy of Tables 1 to 11 referred in the text has been included and submitted.

4) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly.

Answer: The authors would bring to your kind attention that, the Tables 1 to 11 were provided in the supporting information. Now the tables are provided as separate file and the supporting information/supplementary material has been deleted.

Response to the reviewer’s comments

Reviewer 1

The authors sincerely thank the reviewer for the appreciation on the work and their valuable suggestions towards the betterment of the manuscript.

Major Comments:

1. Did the authors observe any pathological lesions in rumen or other compartments of stomach during 15th and 30th day of toxin treatment? Any additional data related to this may strengthen the current findings.

Answer: T2 mycotoxin causes extensive pathological lesions in gastro-intestinal system in goats. We observed pathological lesions in rumen and abomasum as well in group II more evidently. There was peeling of ruminal epithelium and diffuse congestion in abomasum mucosa in group II on 15th and 30th day. Histologically, abomasal layer showed severe necrosis and inflammatory cell infiltration in mucosal layer. Group I also showed mild congestion in abomasum on 30th day. There were no significant histological changes in group I and on 15th and 30th day.

The additional data has been explained in the Results section – clinical signs: Line number 211 to 215.

2. Under the Materials and Methods, in the lines 169-170, DAPI is mentioned as chromogen. However, the authors have used DAB as chromogen in TUNEL kit. This needs to be corrected. Also the sentences in the lines 183-186 should be removed as the authors have performed real-time RT-PCR and therefore sequencing is not required in mRNA expression studies.

Answer: As suggested, we have used DAB in TUNEL kit and in the lines 169-170 DAPI has been corrected to DAB.

Also, the lines from 183-186 have been removed as per the reviewers suggestion.

3. Under the results, in line 215, the authors mentioned that "no mortality was observed during the experimental period". Did they observe any abnormal signs in the toxin treated groups during the study? Supportive evidences may be provided in this section.

Answer: The experimental trial period was 30 days. Both the toxin groups showed variable degree of clinical signs, which included weakness, lethargy, retardation in growth, disinclination to move and reduced feed intake with feed refusal at 15th day onwards. The most consistent clinical signs were diarrhoea at 20th day onwards in both the groups. In 10 ppm group, 4 animals and in 20 ppm group, all 6 animals showed diarrhoea. Control group (III) kids remained healthy and alert, had normal feed intake and did not exhibit any of these signs throughout the experiment.

The supportive evidences/findings have been discussed & incorporated in the manuscript under the results section – Clinical signs: Line number 204 to 209.

4. What is the rationale for assessing IL-1apha than IL-1 beta gene expression, since IL-1beta is more potent than IL-1alpha in stimulating IL-6 release in several tissues?

Answer: Both IL-1alfa and IL-1beta are involved in inducing reactive oxygen species (ROS) but IL-1 alfa is more potent in causing oxidative damage in the tissues. Also IL-1alfa is strong inducer of TNF-alfa and IL-6 in pro-inflammatory process and causing cell damage. Both the cytokines are able to bind to IL-1R receptor and capable of inducing release of pro-inflammatory cytokines. Therefore, mRNA levels of IL-1alfa were assessed in the T-2 toxin pathogenesis. T-toxin binds to ribosomes and activates mitogen-activated protein kinases (MAPKs) along with the regulation of immune and inflammatory genes and lead to stimulation of mononuclear phagocytes which in turn elicit expression of inflammation-related genes in vivo and in vitro including cyclooxygenase-2 (COX-2), pro-inflammatory cytokines and numerous chemokines. For the activation of macrophages, IL-1alfa is important stimulator; therefore, its level is crucial to assess the immune response and inflammatory response in T-2 toxin.

5. The discussion is too descriptive and need to shorten with straightforward discussion.

Answer: As suggested, the discussion part has been shortened by deleting/modifying which was more descriptive

6. The conclusion needs to be rewritten as it is not clear.

Answer: As suggested, the whole conclusion has been rewritten for better understanding.

Minor Comments:

1. The authors should mention the name of the authors while referring to the methodology. e.g. Under Materials and Methods, in line 95, the authors mentioned "produced by fermentation of maize and wheat mixture as per the method described by [32]". Similarly, in line 139, the authors mentioned "MLN and brain tissue homogenates for all the animals on 15th and 30th day according to [33]". The authors name should be mentioned in those places.

Answer: As suggested, in Line 95 & Line 139 of the manuscript the protocol described by AOAC international & Shivasharanappa respectively have been incorporated to refer the methodology. Also the entire manuscript has been checked and followed with the same.

2. In Figure legend 15: Correct the spelling of "sattellitosis".

Answer: As suggested, the spelling of "sattellitosis" has been changed to "satellitosis".

3. Cross check the image magnification (both bright field and EM) in all the figures.

Answer: As suggested, the image magnification (both bright field and EM) of all the figures have been checked and modified.

4. In the Table 1, under Control, with respect to Route of administration, it has been mentioned "Oral (Mixed with feed)". Did the control feed was mixed with any vehicle?

Answer: As suggested, In the Table 1, under Control, with respect to Route of administration has been changed. The control maintenance ration did not have any vehicle and it was free of any mycotoxins.

5. The Table 5 legend reads "T-2 Toxin induced histological alterations (score card) in different organs of young kids on 15th and 30th days fed with 10ppm and 20ppm dose". Remove the word "young kids" and change to "goats".

Answer: As suggested, the word "young kids" has been changed to "goats" in Table 5.

6. Under "Table 9: Effect of T-2 toxin on expression of heat shock protein (HSP) genes in different tissues in 10ppm and 20ppm groups on 30th day", the P value of some of the HSP mRNA expression levels are greater than P<0.05, which suggest no significant difference between the 10 and 20 ppm toxin treated goats and control. However, the "Expression pattern" suggests "up regulation". So check all the parameters.

Answer: As suggested, all the parameters have been cross checked and modified. HSP genes expression particularly in brain, spleen and kidney did not differ between toxin treated groups, however there was higher expression then control group. To avoid confusion, the expression pattern in the tables has been discussed in the discussion part.

7. The authors should strictly follow the references as per the journal format.

Answer: As suggested, the references have formatted as per the journal format.

8. The manuscript should be checked for grammatical corrections and uniformity to match with the journal format.

Answer: As suggested the entire manuscript has been proofread by a professional expertise for any topological errors and modified accordingly as per the journal format.

Reviewer #2:

1. The authors have stated that such studies have been carried out in other animals like sheep, pigs and poultry. In that case, what is the novelty of this study other than the organism used?

Answer: In this study, T-2 toxin induced immunopathology and toxicity was studied in goats because, in India goat production is now emerged as big scale enterprise for meat and milk production and intensive animal farming practice which mainly involves feeding of grains, protein feed and other feed resources. Therefore, contamination of such animal feed with mycotoxins is more likely to cause toxicosis in goats. In order to correlate T-2 toxin effects of other animals, the study was conducted in goats. The novelty involved in this study is that, we have observed complex correlation of HSPs, pro-apoptotic proteins and pro-inflammatory cytokines in response to the toxin treatment. These results suggest that the pathogenesis of T-2 toxicosis in goats employs oxidative, apoptotic and inflammatory mechanisms. T-2 toxin induced significant up regulation of HSPs which is novel finding in goats which indicated HSPs play significant role in pathogenesis of T-2 toxicosis.

As suggested, the novelty of the study has also been described in the manuscript in conclusion and introduction part.

2. It has been mentioned that the toxin was mixed with the feed at specific concentrations. Is there any way the authors could assess the amount of toxin ingested by each animal?

Answer: T-2 toxin was grown on maize grains. The culture of T-2 toxin @ 10 and 20 ppm was thoroughly mixed in maintenance ration and aliquots were taken and quantified by TLC and spectrophotometric analysis for assuring the correct concentration. But it was difficult to assess the amount of toxin ingested by each animal. However, daily feeding of maintenance ration (@300g/animal) two times as ensured that every experimental animal was fed as there was no wastage of feed was observed during the trial period.

3. The authors could give a possible explanation for the elevated levels of HSP molecules in the brain of control animals as opposed to those treated with the toxin.

Answer: The expression of HSPs mRNA in brain did not differ between 10 and 20ppm groups but showed upregulation when compared to the control group.

However, as suggested all the parameters have been cross checked and modified. HSP genes expression particularly in brain, spleen and kidney did not differ between toxin treated groups. To avoid confusion, the expression pattern in the tables has been discussed in the discussion part.

4. The figure legends are obscure and very cryptic. It should be more descriptive for the readers to follow the results.

Answer: As suggested, the figure legends of all the figures have been modified to be more descriptive.

5. There are a few typographical errors that need to be corrected.

Answer: As suggested, the entire manuscript has been checked and proofread for typological errors.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Natarajan Aravindan

7 Feb 2020

Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats

PONE-D-19-26666R1

Dear Dr. Basalingappa,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Natarajan Aravindan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Natarajan Aravindan

28 Feb 2020

PONE-D-19-26666R1

Toxicopathological studies on the effects of T-2 mycotoxin and their interaction in juvenile goats

Dear Dr. Basalingappa:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Natarajan Aravindan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: reviewer comments.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES